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 Though the study of the human proteome (proteomics) is far more complicated than 
that of the genome, it may prove to be the next step toward gaining insight into the 
operation of biological systems.  Understanding the role proteins and peptides play in 
disease, whether that be by their structure, expression or function, could lead to the 
identification of disease biomarkers for diagnosis or engender possibilities for treatment.  
To this end, the work discussed herein delves into the capillary electrophoretic (CE) 
analysis of amyloid beta conformations involved in abnormal aggregation and the 
creation and optimization of a novel bioassay method.  By rapidly analyzing the 
conformations of Aβ present in heterogeneous mixtures, valuable insight may be 
provided into the mechanism of abnormal protein aggregation.  Further, the novel 
bioassay described herein may supply a simplified method for analyzing and quantifying 
many different biologically relevant interactions (i.e. DNA hybridization and 
immunoassays). 
 Capillary electrophoresis is used to study the aggregation pathway of the amyloid beta 
peptide (Aβ).  Since little is known about the mechanism of Aβ fibril formation, this 
research sought to rapidly characterize different conformations of Aβ present in a 
heterogeneous mixture of species using changes in effective mobility and peak shape 
during CE separation.  Electron microscopy and mass spectrometry were used to confirm 
the presence of Aβ in the mixtures and collected peak fractions.  Additionally, the 
interaction between wild type Aβ and a mutated Aβ species resulting in increased 
protofibril formation was analyzed using CE.   
 v
 A novel bioassay method was also developed and termed magnetically assisted 
transport evanescent field fluoro-assays (MATEFFs).  MATEFFs employ magnetic beads 
as both a solid phase for analyte pre-concentration and delivery method to a localized 
evanescent field.   Using this technique, the measurement of signal can be performed 
without call for wash steps and while avoiding matrix interferents present in bulk sample 
solution.  While not limited by analyte diffusion, this method still allows for targeted 
delivery using simple magnetic control of analyte-labeled beads.  This could impact the 
bioassay field, as much focus is currently directed toward miniaturization of bioassay 




The research presented in this dissertation spans my time in two research groups.  Part I 
covers the research efforts under the supervision of Dr. S. Douglass Gilman in capillary 
electrophoretic analysis of amyloid beta peptides.  Part II encompasses the work 
performed under the supervision of Dr. Michael J. Sepaniak in development and 
optimization of a novel bioassay method.  I have attempted to combine the two individual 
projects under the general theme of biomedical methods of analysis.   
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CAPILLARY ELECTROPHORETIC SEPARATION OF 
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CHAPTER 1.                                                                           




 Coupling the separation power of electrophoresis with chromatography 
instrumentation and ease of automation, capillary electrophoresis (CE) has become a 
versatile analytical tool capable of separating a wide variety of compounds.  Owing to 
plug like flow and limited sources of dispersion, CE possesses the highest resolving 
power of any liquid separation method, while consuming only minute sample quantities 
and requiring minimal analysis time.1  Often, a simple change of buffer solution in CE 
facilitates the analysis of a spectrum of relevant samples with various physicochemical 
properties, ranging from metal ions to proteins.  Furthermore, capillary 
electrochromatographic (CEC) techniques, whereby CE capillaries are packed with high 
performance liquid chromatography (HPLC) packing and a voltage is applied for 
separation, are relatively new and offer both the differential partitioning of HPLC and the 
electrophoretic migration of CE with no back pressure and plug like flow characteristics.  
CEC techniques lead to uniquely selective separations and promise superior resolving 
power as compared to traditional HPLC.  With increasing complexity in analytical 
samples, especially those biological in nature, CE and CEC will continue to be essential 
separation techniques due to consequent rapid analysis, high efficiency, and minimal 
sample consumption, even with the existence of some disadvantages such as low sample 
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load and difficult reproducibility.  The work discussed in this section of the dissertation 
will focus on traditional capillary zone electrophoresis. 
Capillary Electrophoresis Fundamentals 
 
History and Theory 
 
 Electrophoresis is simply defined as the migration of charged species when influenced 
by an applied electric field, with separation of these charged species a result of 
differential migration times owing to disparity in charge, size and shape.2  As ions move 
toward the electrode of opposite charge under the influence of an externally applied 
electric field, frictional drag balances the electric force and a steady-state is reached with 
ion velocity (ν e ,cm sec-1) being directly proportional to the strength of the electric field 
(E): 
Eee μν =                                                            (1-1) 
where eμ  is the electrophoretic mobility of the ion (cm2 V-1 sec-1) and   
TL
VE =
                                                              (1-2)  
where V is the total applied voltage and LT is the total length of the separation medium 








                                                          (1-3) 
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where q is the ion charge, η is the buffer viscosity and r is the ion radius.  It is then 
evident that small, highly charged species have high electrophoretic mobilities.3  
 First described by Tiselius in 1930, classic free solution electrophoresis suffered from 
such problems as long analysis times, poor efficiencies, difficult detection and 
automation, and joule heating arising from ionic current passing between electrodes.4 
Joule heating can increase zone broadening due to density and temperature gradients, as 
well as lead to solvent evaporation.  Introducing a support medium to aid in heat 
dissipation, such as a gel, combatted the problem of Joule heating.  However, the high 
surface area available for solute adsorption when using a support, as well as an increase 
in the possible routes of migration, increase zone broadening due to eddy diffusion.  
Furthermore, the addition of the support medium served to make free solution 
electrophoresis an even more labor intensive technique.2, 5, 6  
 Though early experimentation with free solution electrophoresis in capillaries dates 
back to 1967, capillary electrophoresis (CE) in its modern form was developed in the 
early 1980s by Jorgenson and Lukacs, thereby solving many problems of classic 
electrophoresis.7  In CE, fused-silica tubes with inner diameters typically ranging from 20 
to 200 μm and lengths between 10 and 100 cm are used as the migration channel. The use 
of these narrow bore capillaries meant a high surface-to-volume ratio and concomitant 
efficient heat dissipation even when applying large electric fields.  Resultant 
improvement in separation efficiency and decreased analysis time coupled with 
minimized reagent requirements made CE a very attractive solution to analytical 
problems associated with other separation methods.8   
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Instrumentation  
 The instrumentation employed for capillary electrophoretic separations is relatively 
simple.  As shown in Figure 1.1, the basic CE system contains a narrow-bore, fused silica 
capillary whose ends are immersed in electrolyte buffer reservoirs, with said buffer filling 
the inside of the capillary.  Each buffer reservoir contains an electrode connected to a 
high voltage power supply, by which an external potential is applied across the capillary.  
As separations are typically performed from the anode to the cathode (normal polarity), 
the sample is loaded by removing the capillary from the buffer reservoir containing the 
anode and placing the end into the sample reservoir where an external pressure or electric 
field is applied.  The sample reservoir is then replaced by the buffer reservoir and an 
electric field or external pressure is again applied in order to perform the separation.  
Detection can be performed online in capillary electrophoresis by simply removing the  
polyimide coating so that a window is formed on the end of the capillary opposite that of 
injection.3  
 Once injected into the capillary, analytes move under the influence of the applied 
electric field by two independent processes:  electrophoresis and electroosmosis.9  The 
net analyte movement is the vector sum of these two processes (Figure 1.2).  Normal 
polarity conditions would result in migration of only the cationic species toward the 
cathode, with neutral species remaining stationary at the point of injection and anionic 
species being driven toward the anode and thus away from the detector.  Only by the 
process of electroosmotic flow can all ionic species be driven through the capillary and 
thereby detected.   
 5
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Figure 1.2  Illustration of net analyte movement in capillary electrophoresis as the vector 













Electroosmotic Flow (EOF) 
 
 Electroosmosis, playing a fundamental role in capillary electrophoretic separations, is 
solvent flow originating at the solid-liquid interface of the capillary wall due to the  
applied electric field.  This flow is often referred to as the electroosmotic flow (EOF).5  
EOF occurs when exposed silanol groups (SiOH) along the inner surface of the capillary 
wall begin to ionize as SiO- at buffer pH values above 2 due to the range of silanol pKa 
values.  These anionic silanol groups interact electrostatically with buffer cations, 
forming a double layer comprised of both the stern layer (fixed and held tightly by the 
silanol groups) and the diffuse layer (mobile layer pulled toward the cathode once the 
electric field is applied).  This double layer creates a potential difference, or zeta 
potential, along the capillary wall.  When a potential is applied across the capillary under 
conditions of normal polarity, these solvated buffer cations drag the bulk solution toward 
the cathode and thus the detector (Figure 1.3).10     The velocity of the bulk solution 
traveling through the capillary due to EOF (νEOF, cm sec-1) is given by: 
L
Vv EOFEOF ⋅= μ
                                                      (1-3) 
 
where µEOF is the mobility of the EOF (cm2 V-1 sec-1), V is the voltage applied across the 
capillary and L is the total length of the capillary (cm).7  The net migration velocity of an 















































Figure 1.3  Representation of the double layer formed at the capillary surface 





Normally, the magnitude of the EOF is greater than the electrophoretic mobilities of the 
analytes present in a sample.  This leads to the separation of cations, anions and neutrals 
(as a group) in a single run with the order of migration depicted in Figure 1.2.3  It is 
important, though, to control EOF as slow EOF could result in zone broadening and 
increased analysis time.  Several factors influence EOF including buffer pH and ionic 
strength, temperature, and electric field.  Ultimately, anything that affects the inner 
capillary wall and, therefore, the zeta potential will impact EOF.   
 A very important additional benefit of EOF is the flat profile of the bulk flow due to 
the fact that the driving force of the flow arises at the capillary walls.11  This flat profile 
leads to negligible zone broadening due to resistance to mass transfer in the mobile 
phase, in sharp contrast to the laminar or parabolic flow resulting from pressure-driven 
systems such as HPLC.12  Laminar flow can result in significant zone broadening due to a 
velocity gradient, where the solvent velocity in the center is high and drops to zero along 
the walls.13   While EOF aids in high resolution separations and, in theory, only axial 
molecular diffusion occurs in CE, several factors may result in dispersion by their affect 
on EOF or otherwise.14  
Efficiency and Resolution 
 
 Ideally, the lone contributor to band broadening in CE is axial diffusion and the 





=                                                       (1-5) 
where µ is mobility (cm2V-1sec-1), E is applied electric field (Vcm-1), l is the capillary 
length to the detector, and D is the diffusion coefficient of the solute (cm2sec-1).  It can 
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then be inferred that high voltages will increases theoretical plates and improve efficiency 
by minimizing the time for diffusion and that CE can be highly efficient for both large 
and small molecules due to the high mobility of small compounds and low diffusion 
coefficients of larger molecules.15  Unfortunately, other dispersive factors can contribute 
to band broadening and loss of efficiency in CE.   
 Although the small dimensions of the capillaries employed for CE separations help to 
efficiently dissipate heat, with the tens of kilovolts separation voltages normally used for 
efficient separations, joule heating can contribute to band broadening due to changes in 
buffer viscosity.6  Adsorption of molecules to the capillary surface, aside from changing 
the zeta potential and EOF, could result in distortion of peak shape.  Peak fronting or 
tailing could also result from sample overload or from differences in conductivity 
between the running buffer and sample (electrodispersion).12  Additionally, injection plug 
length and hydrostatic flow can play a role in band broadening.  All of these dispersion 
factors can be avoided by a general attentiveness to experimental design including 
judicious choice of buffer concentration, sample ionic strength and concentration, and 
capillary coatings 
 High efficiency is the “claim to fame” of CE and is undoubtedly important; however, 
the ultimate goal in separation science is resolution.  Under conditions such that axial 
diffusion is the sole source of band dispersion, the resolution (R) between two solutes in 








Δ=                                                  (1-6) 
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where μΔ  is the difference in mobility between the two solutes, μ  is the average 
mobility of the two solutes, eofμ  is the electroosmotic mobility, V is the applied voltage 
and D is the diffusion coefficient of the solute.15  Factors that linearly increase efficiency, 
voltage for example, come under the square root sign and do not linearly affect 
resolution. The effects of joule heating limit the application of voltage increases to 
improve resolution.  From equation (1-6), infinite resolution is attained when the average 
and electroosmotic mobility are equal and opposite.  This is not possible, however, since 
it also results in infinite analysis time.  The goal, then, is to balance resolution and time 
by manipulating EOF.  
Detection Methods in Capillary Electrophoresis 
 
 Detectors used in CE must be highly sensitive, a consequence of  the minute sample 
volumes injected and limited observation time for this technique.  Unfortunately, a 
problem arises in that the most sensitive detectors are also the most selective.4  A very 
sensitive, but also universal method of detection in CE would be very useful.  The most 
common means of on-column detection are optical methods, such as ultraviolet (UV) 
absorbance and fluorescence.  Optical methods of detection do face instrumental 
problems such as short optical path lengths defined by the inner diameter of the capillary 
and the cylindrical capillary’s poor optical surface .15  Laser-based detection can solve 
these problems since laser light sources can be focused to very near the diffraction limit 
of light and collection of emitted light at right angles to the excitation source can 
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eliminate stray light using spectral and spatial filters.16  In addition to optical methods, 
electrochemical detection and mass spectrometry find application in CE.   
UV Absorbance Detection 
 
 UV absorption is the most popular detection system for capillary electrophoresis due 
to its universal nature.  On-column detection is achieved by removing a window of 
polyimide coating from the capillary near the end of the column.  This window serves as 
the cell where UV detection is performed.  Sensitivity in absorbance detection is limited 
by the path length, which is defined by capillary inner diameter.  However, this method is 
attractive because a large number of analytes, especially proteins, absorb quite well in the 
UV range.5  The limits of detection for UV absorbance are around 10-6 M, but can be 
optimized by choosing the wavelength for optimal molar absorptivity, using a buffer with 
minimal UV absorbance, as well as extending the pathlength of the capillary.15  
Multiwavelength or scanning UV detection systems can be used in order to detect 
analytes absorbing at different wavelengths in the same run or determine spectral 
information of an unknown.13   
Laser-Induced Fluorescence (LIF) Detection 
 
 Fluorescence detection is attractive because sensitivity is not dependent upon the path-
length.  In LIF detection, a laser serves as the excitation source and is tightly focused on 
the window where the polyimide coating has been removed, with emitted light is usually 
collected at 90° relative to the incident laser beam.  Employing lasers as the excitation 
source, much smaller capillaries can be utilized, as lasers can be focused to nearly the 
diffraction limit of light.16  The detection limits for on-column LIF detection are the 
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lowest reported for CE, with routine LODs around 10-9 M.17  However, with this high 
sensitivity comes increased selectivity.  Commercial lasers are either a fixed wavelength 
or tunable over a small range, with a limited selection of available laser wavelengths.  At 
each available laser wavelength, only select chemical species absorb with high emission 
quantum efficiency.16  In addition, not all analytes of interest exhibit native fluorescence.  
This introduces an additional derivatization step so that non-fluorescent analytes can be 
detected.   
Mass Spectrometric Detection 
 
 Coupling CE to mass spectrometry (MS) is attractive due to the combination of 
sensitivity and structural information provided by MS.12  Though MS is one of the most 
expensive CE detectors, when dealing with complex, especially biological, samples it is 
necessary to identify the components based on something more reliable than migration 
time.  For direct detection, electrospray has been the preferred ionization method, 
although continuous flow-fast atom bombardment, matrix assisted laser desorption 
ionization, and atmospheric pressure chemical ionization have been employed.  Most 
major types of mass analyzers have been used with CE, including quadrupole, magnetic 
sector, time of flight; ion trap and Fourier transform ion cyclotron resonance.  Detection 
limits for CE-MS have been reported in the attomole or zeptomole range and CE-MS 
continues to develop, both instrumentally and functionally.8   
Electrochemical Detection 
 
 Electrochemical (EC) methods of detection in CE are attractive due to the possible 
high selectivity and sensitive detection of electroactive species without derivatization.  
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Detection limits are in the attomole range and not at all affected by the small dimensions 
of CE.  Additionally, instrumentation is relatively inexpensive in comparison to other 
detection methods.  The major dilemma in the use of EC detection with CE is the noise 
arising from high separation potentials native to CE separations.  It becomes important to 
develop a method which isolates the EC signal.18  Though conductivity, a non-selective 
and simple method of ionic species detection in solution, was the earliest form of EC 
detection with CE, current EC detection methods include amperometry, potentiometry 
and scanning electrochemistry.   
Laser Light Scattering (LLS) Detection of Particles 
 
 Light scattering detection techniques have not been extensively used in CE.  However, 
this method has some advantages over other detection methods.  LLS detection is 
performed by focusing a laser beam on the detection window of the capillary and 
detecting the light scattered (usually at angles 15-180° from the incident beam) as the 
analyte passes through the window.  This detection method is based on the concept that 
scattered light contains information, such as size and refractive index, about the scattering 
particle.19  Mie scattering theory can be used to characterize light scattering distributions 
taking into account the effects of particle size, refractive index, detection angle and 
geometry.20  LLS detection is attractive because it is capable of measuring the properties 
of individual particles passing through the laser beam one at a time (using the appropriate 
data collection rates and a tightly focused laser beam) and not the average properties of a 
population of analyte particles.  This allows particles to be individually counted and the 
scattered light intensity of each particle to be related to its size.  However, LLS is not a 
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selective technique, as any system contaminants or particulates, such as bubbles, large 
enough to scatter light will produce a background scattering signal.  However, with a 
contaminant-free system, detection limits can be as low as 1000 particles/mL.21  Lower 
size detection limits for LLS detection have not been fully explored, although reliable 
detection of particles as small as 110 nm has been reported.22, 23  LLS is especially useful 
in mixtures of protein or other biological macromolecules because it is a non-invasive 
detection method that does not require tagging or dilution.  Changes in particle numbers, 
density, length and diameter can be measured and these changes can provide important 
information about such things as aggregation pathways of proteins.19  
Indirect Detection 
 
 With CE being an attractive method of separation for all kinds of compounds, a 
universal detection method is desirable.  Indirect detection methods, whether UV 
absorbance, fluorescence or electrochemical, offer just that.  When an analyte does not 
have any native UV absorbance or fluorescence, a component of the buffer is used to 
absorb light or fluoresce, producing a constant buffer signal in the absence of analyte.  
When analyte is present, it displaces some of the buffer ions and results in a negative 
peak proportional to amount of analyte present.5  Indirect detection methods frequently 
suffers from .column overloading and band broadening, with detection limits related to 
buffer absorbance and stability of transmitted light.18  
Modes of Capillary Electrophoresis  
 
 In attempt to expand the number of applications of CE, several modes of operation 
have been developed geared toward the separation of different types of compounds.4  
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Most of these methods are variations of electrophoresis that were adapted to the capillary 
format.  The most common modes of capillary electrophoresis are capillary zone 
electrophoresis (CZE), micellar electrokinetic chromatography (MEKC) and related 
pseudo-phase techniques, size selective capillary electrophoresis (SSCE), capillary 
isoelectric focusing (CIEF), and capillary isotachophoresis (CITP).18 
Capillary Zone Electrophoresis (CZE) 
 
 Being the simplest and most popular, CZE will be the method used in the research 
discussed herein.  In CZE, essentially free solution electrophoresis, the buffer is the same 
in the reservoirs and the capillary.  The analyte migrates in zones under the influence of 
the applied electric field depending upon the charge/size ratio.2  It is important, in order 
to achieve a good separation with CZE, that the mobilities of each analyte in the injected 
sample differ from one another, that the buffer is homogeneous throughout the capillary, 
and that there is no interaction of the solute or matrix with the capillary wall.  Separation 
of both cations and anions are possible, owing to EOF, while neutrals coelute with EOF. 
Micellar Electrokinetic Chromatography (MEKC) 
 
 MEKC, introduced by Terabe in 1984, allows separation of neutral species.  A 
surfactant above the critical micelle concentration is added to the running buffer and 
neutral solutes partition into the micelles.  The retention factor determines the order of 
separation for the neutral species, making MEKC much like reverse-phase high 
performance liquid chromatography (RP-HPLC).24  Sodium dodecyl sulfate (SDS) is the 
most common micellar phase used in MEKC.  The micellar phase is referred to as 
pseudostationary since, in the case of anionic SDS, it moves slower than the mobile 
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phase.  In addition to micelles, charged cyclodextrins, polymers, bile salts, and 
microemulsions have been employed as pseudostationary phases.  The peak capacity for 
MEKC is limited by the elution range determined by the difference between the EOF (t0) 
and the micelle migration time (tm).18 
Size Selective Capillary Electrophoresis (SSCE) 
 
 In order to permit size based separations, a sieving matrix can be formed within the 
capillary or pumped in under high pressure.  This matrix can be in the form of a gel or an 
entangled polymer.  Analyte migration is still driven by the electric field, but also 
affected by the required migration through the gel or polymer matrix.  This results in 
analyte mobility inversely proportional to size under ideal conditions, as small molecules 
easily pass through pores while larger biomolecules may travel an arduous path.15 
Capillary Isoelectric Focusing (CIEF) 
 
 CIEF separates proteins and peptides based on their isoelectric point (pI) using a pH 
gradient formed inside the capillary by a solution of ampholytes.  Ampholytes are 
zwitterionic and have pI values than span a range of pH values (usually 3 to 9).  The 
capillary is filled with an analyte containing solution of ampholytes and the gradient is 
formed by placing the cathode in basic solution and the anode in acidic solution followed 
by application of an electric field.  The charged ampholytes and analytes will move under 
the influence of the electric field until they reach a region where they become uncharged 
(their pI).  Once this focusing is complete, current no longer flows and the zones are 
passed by the detector either by a separate mobilization step in the absence of EOF, 
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simultaneous focusing and mobilization via careful control of EOF, or mobilization of the 
detector or capillary.12   
Capillary Isotachophoresis (CITP) 
 
 Literally meaning moving at the same speed, CITP utilizes a leading and trailing 
buffer system to create separated analyte zones moving at the same velocity toward the 
detector.  Used to detect either cations or anions, the leading buffer contains the highest 
mobility ion and the trailing buffer the lowest mobility ion.  The analyte containing 
sample is injected between these two zones and the analytes separate in order of mobility.  
The highest mobility compounds have the lowest field strength and vice versa.  
Therefore, all the zones, once equilibrium is reached, will move at the same velocity 
(refer to equation (1-1)).  With no carrier electrolyte, the zones will remain in contact 
with one another.  A major advantage of CITP is the compression of low concentration 
analytes resulting in trace component enrichment.2 
Capillary Electrophoretic Peptide Separations 
 
 An important application of CE is in the area of bioanalytical chemistry, more 
specifically the separation of peptides and proteins.  In the post genomic era and with 
emerging proteomic technology, the ability to rapidly separate mixtures of peptides and 
proteins is of utmost importance.  Proteome research will provide insight into the 
molecular basis of biological processes and aid in development of targeted drug 
therapies.  With protein structure and function determined by their peptide fragments, 
now more than ever it is important to understand the peptide makeup of cells (the 
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peptidome).25  CE has found utility in monitoring of enzymatic peptide digests, 
determining purity of peptide synthesis and in isolating individual peptides from complex 
mixtures.26  Due to high efficiency and ability to resolve small differences in solute 
mobility, CE is capable of resolving peptides with the same charge, but differing in mass 
by one amino acid, as well as peptides that have the same mass but differ in charge by 
one.  CE is non-denaturing, allowing separation of polypeptide molecules in their native 
states.  In comparing CE to complementary techniques in chromatography, such as RP-
HPLC, CE is faster and less labor-intensive.27  Furthermore, the fact that polypeptides 
and proteins have small diffusion coefficients increases separation efficiency in CE, 
whereas these small diffusion coefficients lead to slow mass transfer between stationary 
and mobile phase, increased band broadening and reduced separation efficiency in 
chromatography.6  However, a key limiting factor for CE, especially when applied to 
proteome research, is the limited sample loading capacity.  This can be detrimental in 
terms of the dynamic range provided when interfacing CE with other analytical 
techniques, such as mass spectrometry. 
 Predictive models for peptide migration are necessary for analysis of large numbers of 
peptides contained in cells and tissues.  There is a correlation between the electrophoretic 
mobility of peptides and their charge, size and shape.  The best fit theoretical model for 
predicting peptide mobility, pμ , is the Offord model which accounts for a shear factor 





p =μ                                                               (1-7) 
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where q is the charge of the peptide molecule and M is the molecular weight.  It can be 
difficult to predict the charge of a peptide, however, as a function of pH since pKa values 
of amino acid groups in peptides may differ from that of amino acids in free solution. 
 A major application of CE is found in characterization of peptides and their 
consequent proteins.  The monitoring of dynamic changes in peptide preparations, 
whether chemical modifications or physical alterations, can provide useful insight into 
denaturation, folding/unfolding and conformational states.25  The separation, analysis and 
characterization of peptides by CE is attractive due to the advantages of high efficiency, 
small sample consumption, and ease of automation, but not without challenges.5 
 A continuing challenge in the analysis of peptides with CE is the suppression of 
adsorption to the capillary wall.  Polypeptides have a high affinity to adsorb on the fused-
silica capillary wall believed to be due to electrostatic interactions between positively 
charged residues and negatively charged silanol groups on the inner wall of the capillary.  
This issue, if not addressed,  results in a loss of separation efficiency, poor reproducibility 
and low recovery.29  In dealing with this problem, coatings can be used to shield the 
silanol groups and eliminate sites for adsorption.  However, the coating procedure is 
laborious and has a limited lifetime.  Buffer additives, such as cationic surfactants or 
polymers, are another option to reduce peptide-capillary interactions.  In these cases, high 
ionic strengths are usually required, resulting in problems with Joule heating.  Perhaps 
the simplest approach is to manipulate the pH of the buffer to a value well above the 
isoelectric point (pI) of the peptide, so that it is negatively charged and repulsed by the 
anionic charges on the capillary inner surface.29  As with any CE separation method, 
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appropriate buffer conditions, electric field strength and capillary length, among other 
things, must be ascertained for successful peptide separations. 
Capillary Electrophoretic Analysis of the Amyloid Beta Peptide 
 
 The amyloid-β peptide (Aβ) is comprised of 39-43 amino acid residues and is the 
proteolytic product of the amyloid precursor protein (APP).  Aβ is the primary 
constituent of the extracellular amyloid fibril deposits found in the brains of Alzheimer’s 
disease (AD) patients, in addition to being associated with more than 20 other amyloid 
diseases.30    There are many lines of evidence suggesting that Aβ fibril formation plays a 
central role in the onset of AD.  The overexpression of mutant APP by transgenic animals 
leads to the development of amyloid plaques made up of fibrillar Aβ.  In addition, the 
mutations associated with early onset familial AD all lead to increased production and/or 
deposition of Aβ in the brain.  Moreover, several mutations affecting the processing of 
APP result in increased levels of Aβ, particularly the more amyloidogenic Aβ42 (the 42 
amino acid variant of Aβ peptide).31, 32   
 There is current debate as to the exact identity of the toxic agent in AD.  It has been 
demonstrated that Aβ fibril formation proceeds via a complex multi-step polymerization 
mechanism involving nucleation and elongation steps (Figure 1.4).31  Recent research 
suggests that the toxic form of Aβ may not be the insoluble fibril species, but rather the 
soluble oligomeric intermediate state in the mechanism.  These intermediates are 
sometimes referred to as protofibrils.  Recent evidence better correlates the protofibril 
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Figure 1.4  Aggregation scheme for amyloid beta (Aβ) peptide.  Electron micrographs 












of the role of protofibrils in amyloid assembly could lead to a better understanding of AD 
and suggest a method for inhibiting amyloid pathogenesis.   
 There has been very little reported on the analysis of Aβ peptides by CE.  Varesio et 
al. report the use of CE coupled to electrospray mass spectrometry to detect Aβ 1-40 
peptide, but do not attempt to determine the conformational species present in the 
sample.34  CE separations of different length Aβ fragments have also been reported.35, 
36However, no attempts are made to identify the conformation of Aβ producing the  
observed peaks.    Changes in peak shapes or peak mobilities are attributed to aggregation 
or different species along the aggregation pathway. 
Motivation for Aβ Characterization by CE 
 
 Developing a method for elucidation of the components of a heterogeneous mixture 
containing Aβ species present during fibril formation would facilitate investigation of the 
fibrillogenesis process.  CE provides an avenue to rapidly explore Aβ populations in real 
time under mild conditions while consuming minimal material.  The efficiency of CE 
allows separation of oligomeric species that differ slightly in mass, charge or shape, 
which could result in discrimination between the different conformations of Aβ along the 
pathway to fibril formation, not possible using many other analytical techniques.  
Calibration can be performed using well characterized particles, such as polystyrene 
spheres, in order to better understand changes such as mobility and peak shape for the 
separation of more complex peptide and protein mixtures.  The work described herein 
will seek to rapidly characterize Aβ species using CE, with confirmation of their identity 
by electron microscopy and mass spectrometry.  A better understanding of Aβ 
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aggregation, and protein misfolding in general, would aid in diagnosis of amyloid related 
diseases as well as, and more importantly, the evaluation of possible therapies for their 
treatment and/or prevention.   
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CHAPTER 2.                                                                            





 Protein aggregation normally represents the failure of a protein to reach the correct 
spatial arrangement, folded state, in order to function properly.  If the proper fold is not 
attained, the protein acquires an abnormal conformation, misfolded state, or abnormally 
persists in an intermediate state which would normally be transiently visited along the 
folding pathway.  In these misfolded states, unusually large non-polar areas of the protein 
are exposed and extremely sensitive to intermolecular hydrophobic interactions with 
other misfolded proteins, resulting in aggregation. 37 
 The accumulation of these misfolded proteins is a common feature in several 
neurodegenerative disorders.  Moreover, a class of late-onset, slow-progressing diseases 
seem to result from the gain in function of these misfolded aggregate states.38  The 
extracellular deposition of aggregated protein is a hallmark of Alzheimer’s disease (AD), 
while intracellular protein aggregation characterizes Parkinson’s disease, amyotrophic 
lateral sclerosis and polyglutamine disorders.39  The structure of these disease-related 
protein deposits is commonly referred to as the amyloid fibril.  Amyloid fibrils are 
normally rigid and unbranched structures with a diameter of 5-13 nanometers and a 
length of up to several microns.  Genetic evidence, as well as the correlation between 
fibril deposits and disease, suggest that fibril formation is pathogenic.40  It is important to 
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gain a better understanding of the mechanism by which protein misfolding, and 
ultimately fibril formation, occurs in order to therapeutically battle the neurodegenerative 
diseases characterized by this phenomenon. 
 The amyloid β (Aβ) polypeptide family is the primary constituent of extracellular 
fibril deposits isolated from the brains of AD patients, in addition to being associated 
with more than 20 other amyloid diseases.41  The Aβ monomer is a 39-43 amino acid 
residue peptide that is the proteolytic product of the amyloid precursor protein (APP).  
The predominant species generated by APP metabolism is the 40 amino acid residue 
peptide (AβWT), although many other species can be produced including the more 
amyloidogenic 42 amino acid peptide, Aβ1-42.42  It has been demonstrated that Aβ fibril 
formation proceeds via a complex multi-step polymerization mechanism whereby 
monomer is converted to a soluble oligomeric intermediate, or protofibril, that disappears 
upon further aggregation into the fully formed fibril species.31 There are many lines of 
evidence suggesting that Aβ fibril formation plays a central role in the onset of AD 
including the increase in Aβ production and/or deposition by the mutation associated 
with early onset AD and increased levels of Aβ created by mutations affecting APP 
processing.31, 41   
 There is current debate as to the exact identity of the toxic agent in AD, with recent 
research suggesting that the toxic form of Aβ may not be the insoluble fibril species, but 
rather the soluble protofibril.32, 41  It has been discovered that protofibril content better 
correlates with AD severity than fibril content, and a mutation of the Aβ peptide 
associated with early onset familial AD called the Arctic mutation (AβARC),  an 
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autosomal dominant mutation of the Aβ monomer at the 22nd amino acid residue (E22G), 
when compared to AβWT, forms protofibrils more rapidly and to a greater extent.  This 
suggests that early onset AD resulting from this mutation could be due to the toxic 
protofibril species.41, 43  However, with protofibril formation being a normally transient 
process along the pathway to fibrillization, detailed characterization of protofibril 
structure is rendered difficult.   
 Williams and coworkers, using a screening assay for Aβ aggregation stimulators, 
found that calmidazolium chloride (CC) is particularly effective in stabilizing 
protofibrils.44  When adding 100 μM CC to AβWT monomer, the monomer is rapidly 
converted to a pelletable aggregate or protofibril that persists for days.  This stabilization 
will permit more detailed analysis of these intermediates and possible determination of 
their role in the aggregation process.  
 In the present work, capillary electrophoresis is used to separate samples of AβWT 
monomer, calmidazolium chloride stabilized protofibrillar aggregates (CC-AβWT), and 
fully formed AβWT fibrils.   Additionally, AβARC is separated and compared to AβWT 
monomer.  As previously mentioned, this mutation serves to promote the formation of 
stabilized protofibrils and speeds up fibrillogenesis when mixed with AβWT monomer.  
CE is attractive for these separations due to the advantages of high efficiency, small 
sample consumption, and ease of automation.5  The presented work shows a clear 
distinction between the electrophoretic mobility and peak shape of monomer and fibril 
species.  In addition, the stabilization of an intermediate aggregate by calmidazolium 
chloride allows for the interrogation of this otherwise transient species.  The isolation of 
the different conformational species of Aβ along the aggregation pathway (i.e. monomer, 
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protofibril, and fibril) in the preparation steps reported herein, confirmed by electron 
microscopy, warrant the conclusive identification of the observed peaks resulting from 
each species.  Collected peak fractions were analyzed using matrix assisted laser 
desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) to confirm the 
presence of Aβ.  Furthermore, fibrillogenesis was monitored over a period of several days 
using CE to separate a mixture of AβWT and AβARC monomers.  The observed data was in 
agreement with published reports indicating the acceleration of fibrillogenesis in mixed 
solutions of AβWT and AβARC.  The separations herein provide a means for rapid species 
identification based on a difference in mobility as well as a simple avenue for monitoring 
aggregation and exploring the effect of aggregation inhibitors or accelerators.    
Experimental 
Materials and reagents 
 
 Tris-HCl (tris(hydroxymethyl)aminomethane hydrochloride) and calmidazolium 
chloride were purchased from Sigma (St. Louis, MO).  TFA (trifluoroactetic acid) was 
purchased from Pierce (Rockford, IL).  HFIP (1,1,1,3,3,3-hexafluoro-2-propanol) was 
purchased from Acros (Suwanee, GA).  All buffer and stock solutions were prepared in 
deionized, distilled water from a Barnstead Epure System (18MΩ resistivity, Newton, 
MA) except for calmidazolium chloride, which was prepared at a concentration of 1 mM 
in DMSO (dimethyl sulfoxide). 
Monomer, protofibril, and fibril preparation 
 
 Chemically synthesized AβWT(1-40), amino acid sequence DAEFRHDSGY 
EVHHQKLVFF AEDVGSNKGA IIGLMVGGVV, and AβARC (1-40 Arctic (E22G)) 
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peptides were purchased from Keck Biotechnology Center (Yale University).  These 
peptides were disaggregated in order to remove any preexisting aggregates by a 
TFA/HFIP protocol as previously described.30  The disaggregated peptides were then 
lyophilized for one hr and dissolved stepwise in equal volumes of 2 mM NaOH and 2X 
PBS (pH 7.4), containing 0.1 % sodium azide, to a final peptide concentration of 
approximately 50 μM.  The samples were then centrifuged to remove any remaining 
aggregates (AβWT overnight at 315000 g and AβARC for 30 min at 13000 g).  The 
supernatant concentration was checked using HPLC, and the monomer solutions were 
removed for CE analysis at this point.  In order to form CC-Aβ aggregates, the AβWT 
monomer was combined with calmidazolium chloride to a final concentration of 
approximately 30 μM AβWT monomer and 100 μM calmidazolium chloride in 1X PBS 
containing 10 % DMSO from stock calmidazolium chloride solution.  Fibril samples 
were prepared by incubation of the monomer in 1X PBS at 37 °C for approximately 7 
days.  Thioflavin T assay was used to monitor fibril growth.45  For AβWT and AβARC 
mixture samples, the monomer samples were combined in a 1:1 ratio. 
Capillary Electrophoresis Separations 
 
 All CE separations were performed using a Beckman Coulter P/ACE™ MDQ CE 
System.  The instrument was equipped with a UV source and wavelength selectable UV 
detector with which absorbance detection was performed at 214 nm.  Fused silica 
capillaries (50 μm inner diameter, 358 μm outer diameter; 60 cm total length, 50 cm to 
detector) were placed in the capillary cartridge and thermostatted at 25 °C along with the 
sample holding chamber.  At the beginning of every day, the capillary was flushed 
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sequentially at 20 psi with the following solutions:  1 M HCl for 10 min, Epure water for 
2 min, methanol for 5 min, Epure water for 2 min, 1 M NaOH for 10 min, Epure water 
for 2 min, and 10 mM Tris-HCl, pH 7.8 running buffer for 5 min.  Between runs, a 20 psi 
buffer flush was performed for 5 min.   
 A buffer exchange step was performed on all peptide solutions in order to replace the 
high salt PBS buffer with one more compatible with CE separations.  Microcon® YM-3 
centrifugal filter units (Fisher) were used as directed for buffer exchange procedures on 
AβWT monomer peptide samples.  For CC- AβWT aggregates and AβWT fibril samples, a 
centrifugation step (30 min at 13000 g) was used to pellet out the peptide.  The PBS 
buffer was then removed and the peptide was washed with 10 mM Tris-HCl.  This wash 
step was repeated again before a final resuspension of peptide in 10 mM Tris-HCl.  
Pressure injections were used (5.0 s at 1.0 psi) and the applied separation potential was 
12 kV, producing an electric field of 200 V/cm for all samples.   
 For AβWT and AβARC mixture separations, PBS buffer was exchanged using 
Microcon® YM-3 centrifugal filter units, with the centrifugation step carried out in a 
refrigerated centrifuge to avoid aggregation.  The monomer mixture was then 
resuspended in 2 mM Tris-HCl.  Electrokinetic injections were used for these samples 
(5.0 s at 10 kV), with a separation potential of 12 kV, producing an electric field of 200 
V/cm.   
 Data was acquired using 32 Karat™ Software Version 5.0 from Beckman Coulter.  
Peak fractions were collected using the Manual Fraction Collection feature and 
specifying appropriate peak elution times and peak widths.  Thirty consecutive CE runs 
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were performed, with peaks collected, for each sample.  All data was exported and 
analyzed using Microsoft Excel®. 
Matrix Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry 
(MALDI-TOF MS) 
 
 Mass spectra of collected peak fractions (collected as described above) were acquired 
on an Applied Biosystems Voyager DE-PRO™ MALDI-TOF MS, equipped with a 20 
Hz repetition rate nitrogen laser (337 nm).  The instrument was controlled by Voyager 
Version 5.0 Software with Data Explorer™ and operated in the linear mode.  CHCA (α-
cyano-4-hydroxycinnamic acid) matrix was prepared in acetonitrile/H2O (50:50, v/v) 
containing 1.0 % TFA to a final concentration of 10 mg/mL and combined with equal 
volumes of peptide sample from collected peak fractions.  The samples were then spotted 
on a standard 100 well stainless steel MALDI sample plate. Laser power was adjusted for 
each sample spot, with 200 shots acquired per spectrum.  
Electron Microscopy 
 
 AβWT samples in 10 mM Tris-HCl (fibrillar and protofibrillar) were adsorbed onto 
glow-discharged carbon-coated copper grids.  Grids were then stained with freshly 
prepared 0.75 % uranyl formate.  A Hitachi H-800 electron microscope operated at 100 




Results and Discussion 
Monomer 
 
 The monomeric form of amyloid beta peptide is normally present in human plasma 
and cerebrospinal fluid (CSF), with the 40 amino acid variant the most common.36  
However, upon pathogenesis, the peptide begins to aggregate into soluble oligomers and 
insoluble fibrils that are deposited in the brain.  The 40 amino acid AβWT monomer 
samples used in this work were prepared according to the procedure outlined above to a 
final concentration of 38 µM.  Analysis of the separation of the AβWT monomer species 
by CE reveals two peaks (Figure 2.1).  The first peak was well-resolved, reproducible and 
attributed to AβWT monomer, while the second peak is believed to be a system peak as it 
was not consistently present from run to run.  The baseline dip in Figure 2.1, which 
appears after the monomer peak, is the result of the fraction collection programming 
during which time the end of the separation capillary was transferred to another sample 
vial for peak collection.  Approximately 30 CE fractions were collected and analyzed 
using MALDI-TOF MS.  The inset of Figure 2.1 depicts the observed MS peak, which 
corresponds to the molecular ion, [M+H]+, of AβWT (4330.5 Da).  The weak MALDI MS 
signal could be the result of the low peptide concentrations from CE fraction collection or 
the inefficient MALDI ionization of the Aβ peptide due to limited basic amino acid 
residues.  Based on its pI value of 5.2, AβWT monomer migrated under its anionic form, 
and the peak retention time was changed to electrophoretic mobility using a neutral 
marker.46  An electrophoretic mobility of -1.22 x 10-4 cm2 V-1sec-1 was observed for the 









































Figure 2.1  Electropherogram of 38 μM AβWT monomer sample injected for 5.0 s at 1.0 
psi into a capillary filled with 10 mM Tris-HCl, pH 8.0.  Manual fraction collection was 
used to collect monomer peak, and the inset depicts the collected MALDI-TOF mass 














 multiple injections.  Prior to CE separation, the monomer sample was spotted on a 
copper grid for EM analysis.  As expected, there were no discernable shapes in the EM 
images due to the small monomer size and inadequate resolution of the electron 
microscope (Figure 2.2A).  However, this did confirm that aggregate species were not 
present in the monomer sample, as they would be obvious in the EM images.  
Aggregate  
 
 Studies suggest that the neurotoxic species in AD may be the soluble intermediate 
(protofibril).47  However, because they are transient in the fibrillogenesis process and 
tend to dissociate in buffer solutions, they prove difficult to analyze using many 
biophysical techniques.  Calmidazolium chloride (CC) was previously found to interact 
with soluble Aβ, resulting in a rapid conversion to a pelletable aggregate species.  This 
interaction did not increase the signal from a Thioflavin T (ThT) fluorescence assay used 
to measure fibril formation, suggesting that the aggregate species induced by CC 
resemble a protofibril, and not mature fibril, species.44  In the work reported herein, CC-
AβWT aggregate samples were prepared according to the procedure outlined above to a 
final aggregate concentration of 29 µM.  Analysis of the separation of the CC-AβWT 
aggregates by CE revealed a single, narrow peak with electrophoretic mobility of -1.55 x 
10-4 cm2 V-1sec-1 attributed to CC-AβWT, as well as a peak representing mesityl oxide 
used as the neutral marker (Figure 2.3).  The fact that CC-AβWT elutes after the monomer 
species is presumably a result of the greater negative charge of the aggregate species 
resulting in an increase in electrophoretic mobility.  The presence of CC seems to lead to 




Figure 2.2  Electron micrographs of A) AβWT monomer;  B) AβWT calmidazolium 





















































Figure 2.3  Electropherogram of 29 μM CC-AβWT aggregate sample injected for 5.0 s at 
1.0 psi into a capillary filled with 10 mM Tris-HCl, pH 8.0.  Manual fraction collection 
was used to collect the aggregate peak, and the inset depicts the collected MALDI-TOF 















used to stabilize the protofibrillar intermediate aggregate, the normally transient species 
between the monomer and fully formed fibril can be analyzed using CE.  The dip present 
in the electropherogram is, again, a result of the fraction collection method.  The inset of 
Figure 2.3 illustrates the mass spectrum from the collected CC- AβWT fraction with a 
molecular ion peak at 4328.4 Da.  The CC-AβWT sample, prior to CE separation, was 
spotted onto copper grids for EM analysis.  The electron micrographs revealed large, 
fine-structured spheroids similar to previous reports of isolated protofibrils characterized 
by EM, but no fully formed, mature fibril species (Figure 2.2B).31, 48   
Fibril 
 
 Deposition of insoluble, fully formed fibrils in the brains of AD patients is a hallmark 
of the disease.  Fibrils are normally long unbranched filaments with widths of ~10 nm 
and varying lengths up to several microns.  The AβWT fibrils used in the experiments 
reported herein were prepared according to the procedure outlined above to a final 
concentration of 51 µM.  Analysis of AβWT fibril separation by CE revealed a broad 
collection of peaks with a range of electrophoretic mobilities from -1.98 x 10-4 to -2.88 x 
10-4 cm2 V-1sec-1 (Figure 2.4).  The range of peaks is a result of the heterogeneous nature 
of the fibril sample.  Once again, the fact that the fibril peaks elute after the monomer and 
protofibril species under conditions of normal polarity presumably indicates that this 
AβWT species possesses a greater negative charge relative to the radius change, resulting 
in increased electrophoretic mobility.  The peaks corresponding to the fibril species were 
again collected using manual fraction collection and analyzed using MALDI-TOF MS to 











































Figure 2.4  Electropherogram of 51 µM AβWT fibril injected for 5.0 s at 1.0 psi into a 
capillary filled with 10 mM Tris-HCl, pH 8.0.  The separation potential was 20 kV.  
Manual fraction collection was used to collect the fibril peak, ,and the inset depicts the 








4330.1 Da, as shown in Figure 2.4.  In addition, the EM images from this sample reveal 
the characteristic long, unbranched rod-like fibril structure (Figure 2.2C).   
 MALDI-TOF Analysis 
 
 Fractions of all CE separated AβWT samples were collected and analyzed using 
MALDI-TOF MS as discussed in the experimental section.  Each collected fraction 
produced a single, representative peak in the mass spectra resulting from the [M + H]+ 
ion of AβWT peptide, which has a molecular weight (MW) of 4328.9 Da (i.e. a molecular 
ion [M + H]+ of 4329.9 Da).  Although the peaks in each of the three mass spectra 
(monomer, aggregate, and fibril) are slightly different in mass, they are all within the 
mass accuracy of the instrument for the MW of AβWT.  The MS results confirm that the 
peaks collected from each of the separations did indeed contain AβWT peptide.  Since the 
peaks exhibited quite different electrophoretic mobilities, the only conclusion is that they 
represent different conformational species of AβWT along the pathway to fibrillogenesis. 
AβWT and AβARC Mixture 
 
 A mutation of APP, where glutamic acid at the 22nd amino acid residue of the amyloid 
peptide is substituted for glycine (E22G), termed the Arctic mutation (AβARC), results in a 
decrease of AβWT in the plasma of carrier individuals, as well as an increase in protofibril 
formation in vitro.  This suggests that the AβARC mutation initiates an alternate 
pathogenic mechanism for AD manifestation, possibly implementing the protofibril as 
the primary neurotoxic species.49  Since carriers of the Arctic mutation are heterozygotes 
and express both AβARC and AβWT, it is of interest to understand the in vitro behavior of 
mixed solutions.  Previous studies showed that addition of Aβ  to Aβ  samples WT ARC
 40
stabilized the protofibril species, with the protofibril primarily comprised of Aβ .   
For studies reported herein, monomer samples of Aβ  and Aβ  were prepared as 
outlined above to a final concentration of 21 µM and 18 µM, respectively.  Initially, a 
monomer control sample for each Aβ species was separated using CE.  Subsequently, 
Aβ  and Aβ  samples (55 µM) were mixed together in a 1:1 ratio and incubated at 
room temperature in PBS for the duration of the experiment.  Each day, a sample was 
removed from the mixture and the buffer exchanged for CE separation.  The Aβ  and 
Aβ  monomer species had different electrophoretic mobilities of -1.12 x 10  and -1.47 
x 10  cm  V sec , respectively (Figure 2.5).  It is interesting to note the difference in the 
mobilities for these two Aβ species, as they differ only in one amino acid residue.  
However, the replacement of glutamic acid at position 22 by glycine results in a loss of 
charge for Aβ  as compared to Aβ , resulting in a decrease in electrophoretic 
mobility.  For the first separation after mixing of the two monomer solutions (day 0), the 
monomer peak is split because it results from a mixture of Aβ  and Aβ  monomer 
species.  The original separations seen in Figure 2.5 were before the use of a refrigerated 
centrifuge and a second peak in the Aβ  monomer and mixture separations can be seen.  
This peak is believed to be caused by aggregation accelerated by the centrifuge.  A 
refrigerated centrifuge was used in all subsequent separations.  Samples were extracted 
from the incubating monomer mixture each day and separated using CE.  Figure 2.6 
depicts the change in separation of the mixture throughout the experiment.  An aggregate 




























Figure 2.5  Electropherogram of 21 μM AβWT (red), 18  μM AβARC (blue) and a 1:1 
mixture (55 μM) of the two species (black).  All samples were injected for 5.0 s at 10 kV 













































Figure 2.6  Electropherograms of 55 µM 1:1 Aβ :Aβ  mixture from day 1-9 of the WT ARC
fibrillogenesis process.  All samples were injected for 5.0 sec at 10 kV into a capillary 










depleted relative to the Aβ  monomer peak (Figure 2.6 inset).  This result supports 
earlier findings that Aβ  monomer stabilizes protofibril intermediates formed by Aβ  
monomers, but is preferentially excluded from the protofibril and fibril species.   This 
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Conclusions and Future Work 
 
 Part I of this dissertation highlights the decisive identification of three conformational 
species of Aβ along the aggregation pathway (monomer, aggregate and fibril).  This is the 
first report of the separation and conclusive identification, using electron microscopy and 
mass spectrometry, of the aforementioned Aβ conformations.  Clear distinctions are made 
in electrophoretic mobility and peak shape for each conformation of Aβ analyzed.    The 
results reported herein would make possible rapid species identification and screening of 
aggregation accelerators or inhibitors.  Moreover, the separations performed on the 
Aβ :Aβ  mixture demonstrate the ability to monitor aggregation of Aβ peptides over 
time, possibly shedding light on the elusive mechanism of aggregate and fibril 
formation.   Work on this project is ongoing and recent experiments support the 
findings reported herein.  Additionally, continuing work established a detection limit of 4 
µM for the monomer species of Aβ at a signal to noise ratio of 3.   ThT fluorescence 
studies of the Aβ fibrillization process correlated well with the results of CE separation 
and proved the importance of monomer sample preparation, as in vitro studies are 
extremely susceptible to experimental conditions used in sample preparation, and the 





PART II .                                                                  
DEVELOPMENT OF MAGNETICALLY ASSISTED 

















CHAPTER 3.                                                                            
INTRODUCTION TO IMMUNOASSAYS AND EVANESCENT 
SENSING 
 
 Taking advantage of the specific affinity of an antibody for its target antigen, 
immunoassays have developed into one of the most fruitful contributions to medicine and 
life science of the last century.  Dating back to 1900, the immunoassay concept originated 
with the blood typing research of Ehrlich and Landsteiner.51  The modern immunoassay 
was detailed in the late 1950’s with the investigation of diabetes by Berson and Yalow.52  
In their research, they experimented with radiolabeled and unlabeled insulin and 
described the first radioimmunoassay, winning the Nobel Prize in 1977.  Today, 
immunological techniques are involved in over one billion clinical tests annually in the 
United States alone, ranging from drug tests to pregnancy tests.  However, immunoassay 
utility has not been confined to the medical field, as they have found application in 
environmental, food, pharmaceutical, veterinary and forensic sciences.53  In addition to 
the range of applications, there have been many novel and clever immunoassay designs 
introduced which sought to enhance sensitivity, simplify protocols, and/or increase 
throughput.  The concept of Magnetically Assisted Transport Evanescent Field Fluoro-
assays (MATEFFs) aims to reconcile the advantages of some current immunoassay 
strategies while implementing, for the first time, a localized evanescent sensing surface 
and magnetic delivery of a target analyte to the surface for detection. 
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Immunoassay Theory and Basics 
The Antibody 
 
 It is serendipitous that nature provides the key element used in the study of so many 
biological processes.  The antibody is a protein belonging to the immunoglobulin family, 
and is produced in humans and animals in response to some foreign substance, or antigen.  
The most common class of immunoglobulin and that which provides the majority of 
antibody based immunity is IgG, although there are also IgM, IgA, IgD, and IgE 
subclasses with different biological properties and response to antigen.  The typical 
structure of IgG is illustrated in Figure 3.1.  Each type of antibody is made up of a Y-
shaped monomer unit comprised of four polypeptide chains:  two identical heavy chains 
and two identical light chains connected by disulfide linkages.  Each light chain has a 
molecular weight of about 25,000 Da and is composed of both a variable (VL) and 
constant domain (CL).  The heavy chains, with a molecular weight of 50,000 Da (making 
the entire antibody structure ~150,000 Da), contain one variable domain (VH) and three 
or four constant domains (C , CH1 H2, CH3) depending upon the subclass.  The variable 
domains, at the two tips of the Y structure, differ in amino acid composition and 
determine the antibody specificity for a particular antigen.  Antibodies can be 
proteolytically digested into Fab, F(ab’)2 and Fc fragments, depending upon the cleaving 
enzyme employed.  Papain cleaves above the disulfide linkages which act as a hinge, 
forming two Fab fragments and the Fc portion, while pepsin cleaves below the hinge 
leaving one F(ab’)  portion and the Fc portion.  The Fab and F(ab’)2 2 fragments are 
responsible for antigen binding,  with the Fc portion mediating the physiological effect 
upon antibody response.    
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 Antibodies can be elicited against a large variety of compounds (antigens), both 
natural and man-made, as a result of the enormous number of possible amino acid 
sequence combinations within the binding site.  Once obtained, the antibody is specific 
for its target antigen (more so than most other reagents), able to bind to diminutive 
concentrations of analyte in the presence of many similar substances.  Small molecules 
that are not able to stimulate an immune response on their own, termed haptens, can be 
attached to a large carrier molecule (bovine serum albumin, for example) for antibody 
generation in response to the hapten-carrier adduct.  One of the resulting antibodies may 
then be specific for the small molecule even in the absence of the carrier molecule, 
facilitating generation of an antibody for a molecule that would otherwise be 
unrecognizable to the immune system.  Further, with the development of recombinant 
techniques allowing rapid cloning and DNA characterization, antibodies are now being 
engineered to produce specific functional properties for a desired application.54   
 The strength of binding between an antibody and its antigen is dependent upon the 
sum of these contributing non-covalent forces; electrostatic interactions, hydrogen 
bonding, Van der Waals forces, and hydrophobic interactions.  Van der Waals and 
hydrophobic forces operate over short distances due to structurally similar surfaces, while 
electrostatic interactions and hydrogen bonding are a result of specific reactive groups 
shared by the antigen and antibody.  Though antibody-antigen interactions are non-
covalent, the affinity of an antibody for its antigen can be quite high.  The affinity 
constant (Ka) measures the “tightness” of binding between one antibody binding site and 
the antigen epitope for which it is specific, and represents the ratio of bound to unbound 







=                                                        (3-1) 
where [Ag] represents concentration of free antigen, [Ab] signifies free antibody 
concentration, and [Ag-Ab] corresponds to the concentration of antigen-antibody 
complex.55  Typical affinity constants for IgG antibodies are 105-109 L/mole, but some 
antibodies can have affinity constants as high as 1013 L/mole.56  Sometimes, a better 
measure of binding in a biological system is the antibody avidity, which represents the 
overall binding between an antibody and antigen  This includes binding between multiple 
epitopes of an antigen and the different binding sites for the antibody (IgG has two 
possible binding sites).57 
 Antibodies can be either monoclonal or polyclonal, and both are useful depending 
upon the immunoassay application.  Polyclonal antibodies (PAbs) are a result of classical 
immune response whereby an injected antigen stimulates production of many antibodies, 
recognizing several epitopes on the antigen.  Because of the heterogeneity of PAbs, the 
effect of small changes in an antigen epitope is less likely to be significant.  Additionally, 
PAbs are stable in a range of pH and salt concentrations, and less likely to be altered by 
covalent attachment of a fluorophore or other reporter molecule.  Since PAbs are 
produced by a large number of B cells in response to the antigen and are therefore a 
combination of antibodies with unique specificities, they are generally more specific than 
monoclonal antibodies (MAbs).57  MAbs, first developed by Kohler and Milstein some 
30 years ago, are produced when single B-cells are fused with immortal myeloma cells to 
produce a hybridoma that can yield multiple copies of the exact same antibody.58, 59  
MAbs are homogenous and consistent, making them quite useful when evaluating 
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conformational changes or protein interactions.  However, this homogeneity renders them 
much more susceptible to small changes in epitope structure.  MAbs are constantly 
generated once a hybridoma is successfully created, making them a renewable resource.  
Furthermore, MAbs are generated at a higher concentration and purity for a given 
antibody than PAbs.  The generation of MAbs is expensive, time consuming, and requires 
considerable technical skill as compared to PAbs.  This is not an issue, however, if the 
antibodies are readily commercially available.  The decision of whether to use PAbs or 
MAbs is, again, dependent upon the intended use.  In summary, PAbs are generally more 
robust, can be generated by a variety of species, and are more tolerant of small 
conformational changes in the antigen.  MAbs, on the other hand, are excellent primary 
antibodies because of their specificity and yield reproducible results due to their 
homogeneity. 
Immunoassay Classification 
Competitive vs. Non-competitive 
 
 Immunoassays can normally be categorized as either competitive (reagent limited) or 
non-competitive (reagent excess).  Competitive assays normally require a fixed 
concentration of labeled antigen (or tracer) that competes with unlabeled antigen for a 
limited number of antibody binding sites.  The signal from this form of competitive 
assay, as it is generated by the tracer antigen, is inversely proportional to the 
concentration of unlabeled antigen in the sample.  An example is illustrated in Figure 
3.2A.  Alternatively, the antibody can be labeled and allowed to react with bound antigen 





Figure 3.2  A) Competitive immunoassay illustration (solid phase separation).  B) Non-









the labeled antibody bound to the surface is measured and is, again, inversely 
proportional to the sample antigen concentration.   
 In a non-competitive assay (sandwich) format, the antigen is normally bound by two 
antibodies; one that acts as the capture antibody and one that is labeled and acts as a 
reporter antibody.  An example is shown in Figure 3.2B.  In this case, the signal 
generated is directly proportional to the concentration of analyte.  In order to carry out a 
sandwich assay, the antigen of interest must contain two separate epitopes, or antibody 
binding areas.33, 58     
 When choosing between non-competitive and competitive assay designs, several 
factors must be considered.  Normally, small molecules are analyzed using a competitive 
immunoassay format since they offer only one site for antibody binding.  Additionally, 
competitive assays are sometimes preferred when analyzing a broad range of analyte 
concentrations.  Non-competitive assays, on the other hand, have many advantages over 
competitive assays.  They are normally faster and easier to use on-site, have greater 
specificity for the target analyte, and boast lower limits of detection.60-62  For these 
reasons, the sandwich assay design will be implemented in the work discussed in this 
dissertation.   
Homogeneous vs. Heterogeneous 
 
 Immunoassays are also classified as either homogeneous or heterogeneous, depending 
upon whether or not a solid phase is employed.  Homogeneous assays do not require the 
separation of bound and free analyte/antibodies before signal measurement.  In these  
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cases, the act of binding between the antibody and antigen results in some modulation of 
signal that can be detected in the presence of free antigen and antibody (Figure 3.3A).  
The level of modulation is a factor in limiting sensitivity since there must be a clear 
differentiation between signal and background.  Homogeneous immunoassay strategies 
involve turbidity measurement, fluorescence protection, fluorescence energy transfer, and 
fluorescence polarization, to name a few.53, 63-65  The use of homogeneous assay 
techniques is obviously attractive as it simplifies the steps and decreases the time 
required for the immunoassay.  In theory, the homogeneous assay should be more 
sensitive than its heterogeneous counterpart, as complicated and possibly denaturing 
wash steps are avoided.  However, the sample matrix proves to be a formidable foe when 
attempting to decrease background signal.  Furthermore, many homogeneous assays do 
not realize the full potential of decreased analysis time since the addition of several 
reagents is required prior to detection. 
 In heterogeneous assays, either the antigen or antibody is immobilized on a solid 
support surface.  After allowing sufficient time for binding between the antigen and 
antibody, a wash step removes the free antigen or antibody before signal measurement 
takes place (Figure 3.3B).  It is advantageous to remove the sample matrix, especially in 
those cases where the matrix is biological in nature with the presence of many possibly 
interfering species.  Furthermore, solid-phase immunoassays facilitate concentration of 
the bound complex on a surface for detection, such as in the case of strip kit pregnancy 
and ovulation tests.  However, heterogeneous assays are generally time and reagent 
consuming, as the antibody or antigen must diffuse to the solid surface for binding to take 





Figure 3.3  A) Example of homogeneous immunoassay.  B) Example of heterogeneous 











 Virtually all immunoassays rely on the use of a label for signal generation.  There are 
a variety of labels currently employed in the immunoassay field including, but not limited 
to, radioisotopes, enzymes, fluorophores and particles.68  Radioimmunoassays (RIAs), 
introduced in the 1950s, were very common in early immunoassay research.  
Radioisotopes are unstable atom variants that spontaneously emit energy in the form of 
particles or electromagnetic particles as they decay to a more stable state.  The half-life, 
or time required for half of the radioisotope to decay, is specific to each isotope 
employed, with the most commonly used isotope being Iodine 125 (half life of 60 
days).53  Radioisotopes are easily detected with minimal interferences, but require a 
separation step, special detection equipment, and special precautions for disposal.68   
 Enzyme labels, introduced in the 1970s, are now the most widely used immunoassay 
label.  Benefiting from the catalytic properties of enzymes to generate colored, 
fluorescent or luminescent compounds from neutral substrates, detection limits for 
enzymeimmunoassays (EIAs) can be quite low.  However, signal generation in EIAs is 
susceptible to interferences from temperature, pH, and possible enzyme inhibitors.  
Consequently, special skill and experience is required in order to optimize not just the 
antibody-antigen interaction, but the production of signal.69  The most commonly used 
enzymes for EIAs are horseradish peroxidase and alkaline phosphatase, with different 
substrates employed depending upon the signal source chosen.   
 Fluoroimmunoassays (FIAs) have gained in importance to the immunoassay field due 
to the inherent sensitivity of fluorescence spectrometry, commercial availability of a large 
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number of fluorophore labeled antibodies, and the increase in availability of cost-
effective lasers for excitation.  Fluorophores absorb light of a specific wavelength, and 
emit a photon of longer wavelength as they return to the ground state.  This process can 
occur many times until some chemical damage or modification results in loss of the 
ability to fluoresce.  FIAs suffer from high background, especially in biomedical analysis, 
as a result of scattering and autofluorescence from the sample matrix and are sensitive to 
temperature, pH and dissolved oxygen.  The difference between excitation and emission 
wavelength (Stokes shift) should be maximized in order to minimize noise from incident 
light scatter, and the quantum efficiency, or proportion of absorbed energy that is re-
emitted, should be as close to a value of 1 as possible. Fluorescein, rhodamine and their 
derivatives are most commonly employed in FIAs.  More recently, quantum dots have 
become attractive fluorescent reporters with their high quantum yields, sharp emission 
spectras, chemical and photostability, tunability, and long shef-lives.  These features 
make them quite attractive for multiplexing and ultrasensitive applications.70  All 
immunoassay research in this dissertation made use of FIA techniques.71 
 Finally, particles ranging from dyed latex to colloidal gold to liposomes have been 
used as labels in immunoassay.  Dyed latex labels are employed in some over-the-counter 
pregnancy tests in order to produce a visually recognizable response.  Colloidal gold has 
been used as a label in order to aid in visualization by electron microscopy or to allow 
measurement of optical property changes upon binding and aggregation.  Additionally, 
liposomes can be used in agglutination reactions upon immunocomplex formation or 
liposome lysis resulting in release of a trapped marker can be used for amplification.53, 68 
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Current Efforts in Immunoassay 
 
 The current push in immunoassay development, as in so many other areas of science, 
medicine, and technology, is toward miniaturization.  The microarray immunoassay 
offers the ability to detect multiple analytes simultaneously in the same sample using 
spatially isolated individual immunoassays on a solid surface.  Theoretically, these assay 
formats can be at least as sensitive as their macroscopic counterparts.    It is imperative 
that antibody affinity and the number of active capture antibodies be maximized for 
microarray formats to be successful.  This will require superior binding capacities on the 
solid surface and efficient binding strategies in order to retain maximum antibody 
activity.  Since antibody microarrays depend heavily upon mass transport to the surface 
for binding, anything that improves the mass transport can potentially improve 
sensitivity.62, 72, 73  The research efforts discussed in the following two chapters of this 
dissertation attempt to improve upon current bioassay methods and address the issues that 
will impact their success in the future. 
Total Internal Reflection 
Theory and Applications 
 
 When light travels across the boundary between two mediums possessing different 
refractive indices, the beam will normally be both refracted and reflected.  However, 
under the special case where the light is traveling from a high index of refraction medium 
to one with a lower refractive index and the angle of incidence at the interface is greater 
than the critical angle, total internal reflection (TIR) will occur.    The critical angle is the 
minimum incident angle at which TIR will occur, where the incident angle is measured 
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with respect to the normal at the boundary.  Applying Snell’s law, the fundamental law 
governing the refraction of light, where the angle of refraction is 90º, the critical angle, 





c =θ                                                        (3-2) 
where  is the refractive index of the less dense medium and  is the refractive index 
of the more dense medium.  At the precise critical angle, light will be reflected along the 
boundary between the two materials.  At angles greater than 
2n 1n
cθ , the light will be totally 
reflected except for an evanescent wave (EW) that penetrates into the lower refractive 
index medium (Figure 3.4).  Evanescent means “tending to vanish”, which is appropriate 
considering the EW decays exponentially as it penetrates into the lower refractive index 









λ                                                  (3-3) 
where λ is the wavelength of light and θ is the incident angle.  The intensity of the 
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 The most recognized application of TIR is in fiber optics, where this property of light 
is used to transmit focused light without significant loss and revolutionized the 
telecommunications industry.  However, the localization of the evanescent field at the 



















when the goal is not just to confine light within a TIR element, but to make use of the 
EW radiation for probing materials on the TIR element surface.   
 Currently, attenuated total reflectance (ATR) is used for absorbance measurements of 
samples (liquid or solid) directly in contact with an ATR crystal or prism.  The shallow 
EW is advantageous when analyzing thin films or samples that are too optically dense for 
standard transmission techniques.  Additionally, total internal reflectance fluorescence 
(TIRF) can be used to interrogate fluorescent molecules that are either tethered or in close 
proximity to a surface.  With TIRF microscopy, developed in the early 80’s by Axelrod, 
one can overcome the diffraction limit of light for excitation and illumination of 
molecules or specimens immediately adjacent to a glass/liquid boundary.76  This has been 
invaluable in selective visualization of cell membranes, as well as cell-surface 
interactions, molecular dynamics of DNA and unfolding of immobilized proteins.77-79  
With the introduction of microarray technology, detection of bioanalytical system 
interactions (hybridization or antigen/antibody binding) using TIRF has appeal.80, 81  
Target molecules from within a sample medium can be examined, taking advantage of 
the high sensitivity provided by fluorescence spectroscopy, without significant 
interference from the bulk matrix.  TIRF will be implemented in the research discussed in 
the following chapters of this dissertation.   
Transducers 
 
The reflection elements, or transducers, used for EW excitation can take several forms.  
The transducer refractive index will determine the range of incident angles that can be 
interrogated above the critical angle and, therefore, the possible range of penetration 
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depths, making high refractive index materials the most popular choice.  The simplest 
structure is that of the prism, or single reflection element.  Normally, a laser beam is used 
to illuminate one edge of a prism, with the EW created at the base of the prism if the 
incident angle is greater than the critical angle.  The sample can be placed directly on the 
prism base for examination.  Using a right angle prism, TIR will take place once at the 
prism base resulting in a single EW spot of uniform intensity with dimensions that 
depend upon the laser spot size and focusing optics.  The simplicity of laser coupling and 
EW creation make this approach attractive for interface studies of cells, proteins and 
DNA.  However, the single internal reflection element design does not lend itself to 
multiplexed applications. 
 Waveguides are structures that literally guide waves (electromagnetic radiation) by 
way of repeated TIR.  The cylindrical fiber optic, as mentioned above, is the most 
common type of waveguide, but the discussion in this section will be limited to planar 
waveguides.  Bulk planar waveguides, a type of multiple internal reflection element, are 
appealing because of their 2-dimensional surface which makes possible patterning of 
multiple arrays or attachment of microfluidic architecture.  Bulk planar waveguide 
thickness is large in comparison to the wavelength of incident radiation.  One example of 
a bulk planar waveguide is a simple microscope slide with a thickness of approximately 1 
millimeter.  In this arrangement, multiple modes of radiation are allowed at a given 
wavelength.82  Coupling of radiation into a multi-mode waveguide is simple as it only 
requires direction of the incident beam onto the end face of the waveguide at an 
appropriate angle.  The light will then be confined and guided by TIR within the 
waveguide.  The relatively large face of a bulk planar waveguide allows for slight 
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changes in alignment without compromising efficient coupling.  Further, bulk planar 
waveguides are commercially available and inexpensive.  While the number of 
reflections within the waveguide (NR) is a function of waveguide thickness (t), incident 
angle (θ) and length of the waveguide (L) as given below, 
)tan(2 θt
LN R =                                                            (3-5) 
80the evanescent field on the waveguide surface can be made essentially uniform.   
Cylindrical lenses focusht in only one axis, so that light focused by a cylindrical lens to a 
narrow slit on the edge of the bulk waveguide will be guided in an un-collimated manner 
through the waveguide with divergence of the beam in only the direction of propagation.  
This results in an area of uniform EW illumination after just a couple of reflections that 
will serve as a sensing field, as compared to several discrete EW spots without the use of 
a cylindrical lens (Figure 3.5).      
 Integrated optical waveguide (IOW) thickness is comparable to the wavelength of the 
propagating light.  For this reason, there are approximately 103-104 reflections/cm of 
beam propagation when using IOWs.83  This results in overlap of discrete reflections so 
that they become virtually indistinguishable, resulting in high light intensity and 
significant improvement in sensitivity over thicker bulk optical waveguides.80  Figure 3.6 
compares a bulk waveguide to an IOW.  However, other criteria come into play when 
choosing the appropriate waveguide system.  IOWs are typically able to support only one 
mode of radiation, making coupling an issue.  Simple end coupling is no longer an 







Figure 3.5  A)  Propagation of light through a waveguide without focusing.  B)  
Propagation of light through a waveguide with cylindrical lens focusing to create an area 















Figure 3.6  A)  Bulk optical planar waveguide regime.  B)  Integrated optical waveguide 










waveguide.  The angular alignment requirements are, therefore, very precise and 
complicate IOW use.  Furthermore, the mere creation of IOWs is quite a task.  The 
waveguide can be formed using solution phase techniques such as spin or dip coating, 
normally used for polymer materials.  Deposition procedures can also be employed, 
creating sputtered or vapor deposited films.  Ion exchange techniques can be used to 
produce graded index waveguides with a gradual transition from the substrate to 
waveguide refractive index.  Additionally, sol-gel processing can be used to produce high 
quality metal-organic thin films from solution phase processes.  All of these techniques 
require tolerances on the tens of nanometers scale and, as such, result in high cost of 
fabrication and complicated processing steps.84  
 
EW Technology and Immunoassay 
 
 While the field of immunoassay, and bioaffinity sensor systems in general, have 
benefited from the use of evanescent wave excitation, there is a key drawback.  Whether 
using optical fibers or planar waveguides, the biological system of interest (antibodies, 
proteins or DNA, for example) is immobilized on the waveguide surface using covalent 
immobilization, physical adsorption, or entrapment within polymer matrices.  The result 
of this surface immobilization is limited mass transport.  The assay is, then, diffusion 
limited and signal may take hours or even days to develop.85   
Magnetic Particles 
 
 Besides the hot research area of microfluidics and other miniaturized systems, 
microparticles and nanoparticles are garnering much attention in the scientific 
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community.   While functional microparticles or “beads” can serve as useful mobile 
substrates in many bioassay formats, the advantages are compounded when the beads are 
magnetic.  Magnetic beads, aside from having the large surface-to-volume ratio and 
amplified interaction of the surface with passing fluids, can be magnetically controlled 
independent of normal fluid flow.  This increases the relative bead motion with respect to 
the surrounding fluid medium and enhances sample pre-concentration on the magnetic 
bead surface.86  For fluid manipulation of beads, the magnetic force must be greater than 
the hydrodynamic drag force acting on the particles.  For this research, the use of an 
external permanent magnet was sufficient to meet the above conditions.  In general, 
magnetic beads can have a single magnetic core (usually in the case of nanoparticles) or a 
core composed of multiple magnetically interacting nanoparticles encapsulated in a non-
magnetic matrix.  Commercially available magnetic beads, used in the research discussed 
in this dissertation, are provided with various surface modifications and chemistries, high 
iron content, and narrow size distribution.  These particles are superparamagnetic, 
meaning they exhibit magnetic properties when in the presence of a magnetic field, but 
have no residual magnetism once the magnetic field is removed, rendering them easily 
recoverable in solution.  They additionally boast high magnetic mobility and low 
sedimentation rates.  Figure 3.7 illustrates the spherical shape and low sedimentation rate 
of the commercial products used in the research discussed in the following chapters.  
Magnetic beads have been employed for cell separation, immunoassays, DNA 
hybridization studies and drug delivery. 
 67
 
Figure 3.7  Illustration of slow sedimentation rate and excellent size distribution for 1 µm 
















MATEFFs Design Rationale 
 
 Both homogenous and heterogeneous assay formats have benefits and drawbacks.  
Selective sequestration of analyte on a solid surface, as with heterogeneous assays, has 
advantages, but requires wash steps.  The measurement of signal without need for wash 
steps, as in a homogeneous assay, is attractive but normally results in background 
interference.  MATEFFs utilize magnetic beads as the solid phase for analyte 
sequestration, resulting in analyte concentration and subsequent delivery to a localized 
field created by TIR for detection.  This eliminates both the need for multiple wash steps 
and background interference from bulk matrix components.  The magnetic beads are 
easily dispersed and recovered in solution, making it possible to not only regenerate the 
EW sensing surface between measurements by simply removing the magnet that retains 
the magnetic bead plug, but to fully interact with the sample solution without relying on 
diffusion to a single spot on a planar surface.  This novel technique that cleverly 
integrates, for the first time, concepts that have been researched and implemented for 







CHAPTER 4.                                                                            




 The immunoassay, a diverse suite of techniques combining chemistry and 
immunology whereby an antibody is used in the determination of sample composition, is 
a biomedical tool commonly used in toxicology, drug analysis and immunoscreening 
procedures.87  Antibodies boast strong binding interactions and unique specificity with 
their target antigen, making possible measurements of very low antigen concentration 
even in complex matrices.33  The inherent sensitivity of fluorescence spectroscopy 
combined with the existence of a wide range of commercial antibodies and labels renders 
fluoroimmunoassays (FIAs) an attractive method of analysis.  The two principle 
quantitative protocols for FIAs are heterogeneous assay, requiring a separation step to 
remove bound target analyte from a sample mixture, and homogeneous assay, whereby 
the target analyte is directly detected within the mixture.65 Homogeneous assays are 
attractive due to the preemption of many laborious and time consuming steps necessitated 
by the heterogeneous assay.  However, homogeneous assays suffer from limited 
sensitivity and interference from fluorescent impurities present in the matrix, not to 
mention the fact that many homogeneous assays actually require the addition of several 
reagents before detection.65   
 Conventional immunoassays, performed in microtiter plates, consume large amounts 
of expensive reagents and can take as long as a few days for target molecules to diffuse 
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through solution and completely react with immobilized probes.88  Microfluidic 
separation and fluid handling systems have garnered much attention in the past decade as 
a portable, small footprint means of carrying out chemical and biological processes on a 
manageable, solvent- and sample-conserving platform.89  It is logical, then, that the 
immunoassay format could benefit from these miniaturized systems.   In fact, 
homogeneous and heterogeneous immunoassays have been performed in capillaries and 
microfluidic devices.66, 67, 90-92  For heterogeneous assay application, antibodies and 
antigens were immobilized on microchips with multiple operations performed (loading, 
washing and labeling) before detection.66, 67, 92  In the case of homogenous assays, some 
sort of separation and detection step must follow antigen-antibody complexation in 
solution.  Two groups have reported electrophoretic separation of reaction products from 
a competitive homogeneous assay.90, 91  However, separation can be difficult in systems 
with small differences between free and complexed antigen or antibodies, limiting 
widespread application of this technique.  
 Magnetic microspheres (μspheres) have found utility as solid phases for biomolecule 
immobilization.  In general, μspheres have several advantages when used as the solid 
support in immunoassays, including a large specific surface for binding, mobility of the 
solid phase, and an attendant enhancement in interaction of the phase surface with 
passing fluids.  When the μspheres are magnetic, there are still more advantages. 
Magnetic manipulation of μspheres independent of fluidic flow makes possible the 
delivery of immobilized analytes, be they proteins or small molecules, to a specific zone.  
These μspheres are practical, well tested, and readily commercially available with 
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modifications that allow attachment of antibodies or other specific recognition groups, 
thereby allowing analyte-specific sequestration within a complex matrix.  Finally, 
magnetic μspheres are amenable to miniaturization and multiplexing using different 
capture probes.  In recent work, magnetic μspheres containing an immobilized antibody 
were held stationary in a fused-silica capillary by an external magnet and used to capture 
an antigen in solution, which was subsequently rinsed from the μspheres for downstream 
detection.93  Additionally, a clever heterogeneous sandwich immunoassay was performed 
in a simple microchannel using a stationary plug of magnetic μspheres as the solid phase 
with antigen capture by one immobilized antibody and detection performed by imaging 
fluorescence resulting from a second fluorescent antibody.94  Very recent work by Petkus 
et al. uses magnetic bead rotation and lock in amplification to demonstrate that overall 
assay sensitivity can be enhanced by eliminating the wash step, especially when dealing 
with hapten derived monoclonal antibodies.95 These techniques demonstrate the utility 
and reward of incorporating magnetic bead solid supports into microfluidic devices.  
Nevertheless, there are some aspects of the microimmunoassay that can be optimized 
before realization of the full potential of this method.  For instance, the precise control 
and formation of a small magnetic bead plug in a microchannel is not trivial.  
Inconsistencies in bead plug packing density or length could greatly affect fluid 
dynamics, flow rates, reaction rates, bead plug stability and reproducibility.  Furthermore, 
multiple labeling and wash steps required with the heterogeneous assay format, in 
general, introduce the potential for non-specific adsorption anomalies, complicate sample 
handling and increase time consumption.  The current work seeks to reconcile the 
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advantages of solid support sample concentration with the need to eliminate complicated 
separation steps by, for the first time, combining selective magnetic transport of analyte 
to a highly localized evanescent electromagnetic field. 
 The work presented in this chapter serves as a proof of concept and details the 
development and preliminary optimization of a novel technique, immunological 
Magnetically-Assisted Transport Evanescent Field Fluoro-assays (MATEFFs), which 
combines the advantages of both the homogenous and heterogeneous assay while 
eliminating some of the drawbacks.96, 97 MATEFFs realize selective sequestration of 
target analyte on magnetically controlled beads, affording the heterogeneous assay 
benefit of low detection limits, while still allowing the delivery of the target from within 
the bulk mixture to a localized evanescent field sensing surface.  Evanescent field 
techniques make use of the property of total internal reflectance at an optical interface, in 
this current illustration of MATEFFs defined as the interface between the prism and 
sample.  Total internal reflection (TIR) occurs when light traveling from a higher 
refractive index medium into a lower refractive index medium strikes the interface at an 
angle larger than the critical angle.  The light is totally reflected, except for an 
electromagnetic (evanescent) wave (EW) that is generated at the reflecting surface and 
penetrates a fraction of a wavelength into the lower refractive index medium.  The EW 
intensity decreases exponentially with increasing distance from the interface.   
 MATEFFs employ magnetic μspheres as solid supports for a representative sandwich 
fluoroimmunoassay as well as a medium for transport of this assay to the evanescent 
sensing surface.  Direct detection of bound analyte within the sample mixture is effected 
by driving the μspheres to the prism surface, and thus into the evanescent wave (EW), 
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using an external magnet.  Thanks to the diminutive evanescent field depth, d (~200 nm), 
the magnetically delivered analytes can be detected with fewer complications arising 
from non-optically homogeneous biological matrices. This means a lower background 
(i.e., a higher signal to noise ratio) due to the confinement of the exciting wave to the 
prism surface that will contain a monolayer or more of labeled μspheres for TIR 
fluorescence (TIRF).  The term monolayer is used in discussion of the magnetic particle 
assemblies on the prism surface in this chapter, although the particles are separated by 
some distance due to inter-structure repulsion.  This term is used to differentiate between 
a primarily single bead layer and formation of multiple layers or clusters of magnetic 
beads on the surface.  When referring to a close packed traditional monolayer assembly 
in later discussion, the term traditional monolayer is employed.  Because only a 
monolayer of μspheres is required for optimum technique performance, the need for and 
requisite control of very small well-defined bead beds is circumvented and the magnetic 
transport of solid phase reagents is greatly simplified when it entails only the driving of 
beads to contact an impenetrable optical interface. What’s more, paramagnetic μspheres 
are easily dispersed and recovered in a solution, allowing facile regeneration of the 
localized evanescent sensing surface.  This technique eliminates wash steps without 
compromising sensitivity, all the while minimizing interference from fluorescing species 
present in the bulk sample matrix thanks to a surface-localized evanescent field.  
MATEFFs has been optimized by assessing the impact of background interferents 
(fluorescein), an optically dense matrix (milk), incident angle, magnetic field direction, 
laser power density via focusing and laser power adjustments, and bead concentration.  
Utilizing a model sandwich assay system (biotinylated anti-IgG; rabbit IgG; anti-IgG-R-
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phycoerythrin), the analytical figures of merit for the technique are evaluated and 




 Sodium dihydrogen phosphate, disodium hydrogen phosphate, Tween 20, bovine 
serum albumin (BSA), fluorescein isothiocyanate (FITC), biotin (5-fluorescein), 
biotinylated anti-rabbit IgG capture antibody, rabbit IgG, and anti-rabbit IgG-R-
phycoerythrin (RPE) were purchased from Sigma-Aldrich (St. Louis, MO) and used as 
obtained.  FITC and RPE were used in this work as labels because they can be spectrally 
distinguished reasonably well and are readily available.   Sodium chloride (NaCl) was 
obtained from Mallinckrodt, Inc. (Phillipsburg, NJ) and used as received.  Dynabeads® 
MyOne™ Streptavidin C1 superparamagnetic µspheres (1 µm diameter) were purchased 
from Dynal Biotech (Brown Deer, WI) and diluted using phosphate buffered saline (PBS) 
prepared according to Dynal Biotech recommendations.  All buffers and solutions were 
prepared in deionized, distilled water from a Barnstead 1800 (18 MΩ resistivity). 
Apparatus Design 
 A schematic representation of the MATEFFs instrumental setup is depicted in Figure 
4.1.  The 488-nm beam from an argon-ion laser (Uniphase Model 2201, San Jose, CA) 
was directed through a laser line filter (Edmund Optics, Barrington, NJ) and pinhole 
using first surface mirrors (Edmund Optics, Barrington, NJ).  The beam was then focused 
using a plano-convex lens (Edmund Optics, Barrington, NJ) with either a 125-mm or 
175-mm focal length and sent to a beam steering mirror directly mounted 
 75
 on a rotary stage for controlling the incident angle of the laser beam on the TIR prism.  
To ensure the same spot on the prism surface was illuminated with changing angles, the 
vertical position of the rotary stage was controlled via a single axis translational stage. 
The TIR prism was an inverted right angle BK7 prism (Edmund Optics, Barrington, NJ) 
with n=1.52, surface flatness of  λ/4,  and surface quality 40-20.  By milling flat the angle 
opposite the hypotenuse face of the prism, the prism could be placed flush with the 
surface of a delrin holder fabricated in-house.  The holder contained a sliding block, 
which housed a pressure-formed neodymium bar magnet rated at a 10.7 lb. lift 
(McMaster-Carr, Atlanta, GA).  The block was used to slide the magnet beneath the 
prism, as well as remove it when necessary.   
 A sample compartment was formed from a polydimethylsiloxane (PDMS, Sylgard 
184, Dow-Corning, Midland, MI) reservoir, bored using a modified 1.5 mm syringe, 
placed directly on the prism surface and enclosed with a glass cover slip.  Fluorescence 
was collected through a bi-convex F1 lens, passed through a razor-edge 514 nm Raman 
filter (Semrock, Rochester, NY), and focused onto a Hamamatsu HC120 photomultiplier 
tube-based photosensor module (PMT) (Hamamatsu, Bridgewater, NJ) using another bi-
convex F1 lens.  The fluorescence was additionally filtered before reaching the PMT 
using a narrow bandpass interference filter centered at 580 nm (Edmund Optics, 
Barrington, NJ) for RPE and 532 nm (Melles Griot, Rochester, NY) for fluorescein.  The 
output voltage from the PMT was converted at 1Hz by a PMD-1208LS data acquisition 
board with TracerDaq® software (Measurement Computing, Middleboro, MA).  The 
optical photographs shown in Figure 4.1 demonstrate delivery of the magnetic μspheres 























Figure 4.1 Schematic of MATEFFs Apparatus.  LLF, laser line filter; PH, pinhole; M, 
mirrors; P, prism; L, lens; IF, interference filter; FL, focusing lens;  PMT, 
photomultiplier tube; SMH, sliding magnet holder.  Optical photos (200 µm x 200 µm) 
illustrate surface sequestration of beads.  Inset illustrates the bending of light at the 
interface between prism and solution and the exponential decay of the evanescent wave.  
Refraction (red arrow) occurs at angles smaller than the critical angle, at the critical angle 
(green arrow) the light is refracted at 90° along the interface, and total internal reflection 
 





Labeling of µspheres:  In order to perform the optimization tests, Dynal Biotech 
Dynabeads MyOne Streptavidin C1 μspheres were fully functionalized, using a sandwich 
assay format, with biotinylated anti-rabbit IgG as the capture antibody; rabbit-IgG as the 
antigen; and anti-rabbit IgG RPE as the reporter antibody.  The μspheres were first 
washed with PBS and diluted to 1 mg/mL.  A 400 μL aliquot of μspheres was then 
removed, separated using an external magnet, resuspended in 400 μL of biotinylated anti-
rabbit IgG (0.05 mg/mL) and allowed to incubate for one hour with gentle rotation.  
These µspheres were considered fully biotinylated.  The µspheres were then separated, 
washed two times with PBS, one time with 0.01% Tween 20 in PBS, resuspended in 400 
µL of rabbit-IgG (0.5 mg/mL) and again allowed to incubate for one hour with gentle 
rotation.  These fully antigen labeled µspheres were again separated, washed as described 
previously and resuspended in 400 μL of anti-rabbit IgG RPE (0.1 mg/mL).  Lastly, the 
µspheres were separated, washed and resuspended in 400 μL of PBS.  This fully labeled 
μsphere solution was used for all optimization experiments, with 0.6 μL aliquots used to 
fill the PDMS reservoir for each individual experiment.   
The labeling steps for calibration curve experiments were the same as described above, 
except for the concentration of rabbit IgG antigen.  After fully biotinylating the μspheres, 
they were divided into 50 µL aliquots and labeled using rabbit IgG standards ranging in 
concentration from 20 to 200,000 μg/L, followed by full labeling as previously described. 
For multi-analyte experiments, the DynaBead μspheres were directly labeled with biotin-
5-fluorescein (6000 pmol) by incubating for one hour with gentle rotation. 
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Results and Discussion 
 
 In this work, functionalized magnetic µspheres are driven into contact with the surface 
of a prism, where an evanescent wave has been generated via total internal reflection, 
using a strong external magnet on the underside of the prism.   To our knowledge, this 
represents the first attempt to use magnetic transport of a fluoroimmunoassay to a 
localized field for EW excitation.  Consequently, experimental conditions for the 
MATEFFs technique require optimization.   
 Evanescent wave penetration depths are dependent upon the wavelength of the laser, 
the incident angle, and the refractive indices of the liquid and solid.  At the critical angle, 
light traveling from the high refractive index medium (prism) to the low refractive index 
medium (solution) will be refracted at 90° along the interface.  At any angle larger than 
the critical angle, the light is totally internally reflected except for the EW generated at 
the prism surface.  The penetration depth of the EW increases as the incident angle 









λ                                               (4-1) 
 and nwhere λ is the laser wavelength, θ is the incident angle, and n1 2 are the refractive 
indices of the prism and solution, respectively. 
 In this work, penetration depth is changed by incrementally varying the angle on the 
mirror steering the incident beam.  Initially, the formation of the EW was confirmed by 
magnetically transporting RPE functionalized μspheres to the prism surface and scanning 
through incident angles using the beam-steering mirror until a marked increase in 
fluorescence signal resulted from refraction of the laser light into the bulk solution.  The 
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merit of MATEFFs as a method of delivery to a localized field in the presence of a 
complex matrix was then established by preparing the RPE functionalized μsphere 
solution in a background matrix containing 1 µM fluorescein as a model interferent.  
Figure 4.2 compares the emission of RPE and fluorescein (emission bandpass filters 
centered at 580 nm [10 nm FWHM; 67% transmission] and 532 nm [10 nm FWHM; 45% 
transmission], respectively) as a magnet is used to deliver the μspheres to the EW.   
Because the broad fluorescence emission of fluorescein overlaps with that of RPE, 
corrections were made to the 580 nm emission data in order to eliminate the signal 
contribution from fluorescein, which was determined to be 13% of the fluorescein 
emission at 532 nm.  In addition, a small amount of autofluorescence from the μspheres 
themselves is present at 532 nm and that emission is corrected by subtracting the value of 
autofluorescence determined from the solution of RPE alone.  Starting at an incident 
angle of ~63° and approaching the critical angle (~61°, CA in the figure) the RPE 
fluorescence intensity increases as more molecules are excited by the deeper penetrating 
EW.  The change in fluorescence emission as the incident angle is approached follows 
the shape of the calculated curve for the change in EW penetration depth with incident 
angle change as expected (Figure 4.2 inset).  Once the incident angle falls below the 
critical angle, refraction of the laser beam into the bulk solution causes the fluorescence 
intensity of both RPE and fluorescein to dramatically increase (grey and black bars off 
scale in Figure 4.2) due to excitation of fluorophore in the bulk solution.  This experiment 
was repeated and similar angle-fluorescence trends were observed. The signal resulting 
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Figure 4.2  Comparison of fluorescence emission from fully functionalized RPE µspheres 
in a 1 µM fluorescein solution in the presence and absence of an external magnet field at 
different incident angles.  RPE µsphere emission with magnet (grey bars); RPE µsphere 
emission without magnet (red bar); 1 µM fluorescein emission without magnetically 
delivered µspheres (black bars); 1 µM fluorescein emission with magnetically delivered 
µspheres (blue bars).  The arrow demonstrates the difference between signals when the 
magnetically labeled beads are delivered to the localized field with an external magnet as 
compared to no magnetic delivery.  The insert demonstrates the change in penetration 
depth with incident angle calculated from Equation 4-1
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incident angle upon removal of the external magnet (~1/90th the signal with magnetic 
delivery; red bar) due to transport of the beads away from the interface and out of the 
most intense portion of the EW.  In addition, fluorescein emission is reduced upon 
magnetic delivery of the μspheres to the evanescent field due to displacement of matrix 
volume by the μspheres.  
 These results serve as a preliminary demonstration of the ability of MATEFFs to 
reduce complications arising from spectral matrix interferences.  All further experiments 
were performed at an incident angle ~0.5º above the critical angle.  To further illustrate 
the MATEFFs advantage when dealing with an optically dense medium, milk was used 
as an opaque matrix (Figure 4.3).  The detection of fully RPE functionalized magnetic 
μspheres was realized using the MATEFFs technique in two different milk matrices and 
compared to fluorescence detection of rhodamine 6G in the same matrices using a 
simulated homogeneous assay.  The signal from R6G in 1:1 milk:PBS matrix using the 
simulated homogeneous assay was less than 8% of the signal from R6G in PBS alone.  
Conversely, using the MATEFFs method, the fluorescence signal from immobilized RPE 
in the same milk matrix was nearly 65% that of the signal from RPE in PBS alone  
Optically dense matrices in conventional immunoassays create problems by significatntly 
reducing response intensity, thereby necessitating multiple wash steps to get rid of   
interfering effects.  In MATEFFs, there is only moderate reduction in response intensity 
in the presence of a very optically dense matrix (1:1 milk:PBS), due to passage of the 
emission through approximately 1.5 mm of matrix (see Figure 4.1), and the analyte of 
interest can be detected in the presence of fluorescent interferents because of selective 
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Figure 4.3  Matrix interference experiment comparing MATEFFs technique to a 









steps.   
 It is important that μsphere coverage on the prism surface be maximized, as relevant 
analyte is transported to the EW by the μspheres.  Superparamagnetic particles, when 
placed in a magnetic field, will acquire a magnetic moment and interact by way of 
magnetic dipole forces.86  Because of these dipole forces, the particles will begin to 
cluster into large, column-like structures often called supraparticle structures (SPS), 
which align in the direction of the magnetic field.  For this reason, the effect of magnetic 
field direction on the resulting fluorescence signal from the model sandwich assay system 
was probed.  Micrographs taken in the lab (Figure 4.4) reveal that perpendicular magnetic 
fields, created by a bar magnet with field lines approximately perpendicular to the prism 
surface, cause the SPS to align vertically and grow larger in the vertical direction with 
increasing bead concentration.  In contrast, a magnetic field created by a bar magnet with 
field lines approximately parallel to the prism surface leads to SPS that form horizontally 
along the prism surface.  These micrographs are not indicative of optimized prism surface 
coverage, as they only serve to make a distinction between the parallel and perpendicular 
magnetic fields.  As evidenced in Figure 4.4, a magnetic field that is parallel to the 
surface of the prism yields a greater fluorescent signal at every incident angle tested in 
comparison to a magnetic field perpendicular to the prism surface.  Although the parallel   
magnet orientation proved to be important in maximizing fluorescent signal, presumably 
due to an increase in the amount of functionalized μspheres in contact with the prism 
surface with a parallel magnetic field, perfect parallel field alignment was not critical as 
slight tilting of the bar magnet to manipulate SPS surface placement exhibited no 
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Figure 4.4  The orientation of the magnetic field with respect to the prism surface 
(parallel (black bars) or perpendicular (blue bars)) has a marked effect on fluorescent 
signal.  Once past the critical angle, fluorescence signal from both magnetic fields is off 
scale due to refraction of the laser light into the bulk solution. Optical photos (200µm x 







 The effect of increasing laser power on the ability of the EW to excite bead-bound 
fluorophores was also investigated.  The goal is to evanescently excite the maximum 
number of fluorophores while avoiding any deleterious effects, such as photobleaching, 
bond degradation, or thermally induced migration away from the EW.  In addition to 
varying power over the range available with our laser, we used two lenses with different 
focal lengths; 125 mm that produced a smaller focused diameter of ~77 μm and 175 mm 
that produced a larger focused diameter of ~108 μm.98   The plots shown in Figure 4.5 
demonstrate an expected behavior.  Signals increase rapidly with increasing power at low 
powers but show evidence of the aforementioned deleterious effects at higher powers as 
seen by leveling-off of the plots.   The longer focal length lens probes roughly a factor of 
two greater surface area than the short focal length lens.  The bottom two data points for 
each of the two lenses (each curve) happen to be at equivalent power densities incident 
on the prism surface (~ 30 W/cm2) and show almost a factor of two greater signal for the 
long focal length lens, correlating well with greater probed surface area.  Although the 
larger probe area is desirable in terms of raw signal, it does require larger confinement 
vessels or channels and more beads. 
 As a final optimization study, different concentrations of functionalized μspheres were 
utilized in an effort to achieve the most uniform surface coverage.  When using one  
micron diameter μspheres, the evanescent wave (~200 nm) cannot fully probe the entire 
μsphere, thereby necessitating only a monolayer of beads on the prism surface.  Although 
it is important to maximize surface coverage, any excess bead formation (multilayers or 









0 5 10 15 20 25 30 









Figure 4.5  Assessment of the relationship between laser power and fluorescence signal using 
two lenses with different focal length.  The larger focal length 175 mm lens (red diamonds) 
 








clustering) on the prism surface may hinder TIRF signal collection, as these multilayers 
This is evidenced in Table 4.1, which displays fluorescence signals measured and relative 
standard deviation (RSD) values calculated (n = 4) for six concentrations of 
functionalized magnetic μspheres.  As μsphere concentration increases, the fluorescence 
signal increases and then begins to decrease at the highest measured concentration.  
Additionally, the RSD values decrease and again increase with the concentration of 
μspheres.  A μsphere concentration of 0.6 µg was selected for use in construction of the 
calibration curve due to the desire to conserve sample while maintaining acceptable 
signal and RSD values.   
 The linear dynamic range and detection limits of this immunoassay technique were 
evaluated by constructing a calibration curve (Fig 4.6).  Standard solutions of rabbit IgG 
ranging in concentration from 20-20,000 ng/mL were tested using the MATEFFs 
technique.  A quite respectable linear dynamic range (y(V) = 0.0007x (ng/mL) + 0.111) of 
nearly three orders of magnitude is established (R2=0.991) with a detection limit of 42 
ng/mL (~280 pM) for this particular assay.  Error bars for the calibration curve were 
assigned based on the RSD values defined in Table 4.1 for 0.6 µg bead concentration. 
Table 4.1  RSD values (n=4) and fluorescence signals for 6 µsphere concentrations.
Bead Concentration (µg) Fluorescence Signal (V) RSD Value (%) 
0.15 1.32 7.8 
0.30 1.98 6.8 
0.45 2.06 3.1 
0.60 2.70 5.0 
0.75 3.76 7.9 






























 In order to demonstrate the compatibility of MATEFFs with multi-analyte systems, 
μspheres fully labeled with RPE and fluorescein were employed.  Simultaneous detection 
was achieved by using the two narrow band interference filters, centered at 532 nm for 
fluorescein (Melles Griot, Rochester, NY) and 580 nm  for RPE (Edmund Optics, 
Barrington, NJ), interchangeably.  As mentioned in the discussion for Figure 4.2, 
corrections were made to the data to adjust for autofluorescence from the μspheres 
themselves at 532 nm, as well as the overlap of fluorescein emission with that of RPE at 
580 nm.  Comparison of fluorescence emission from solutions of RPE labeled beads, 
fluorescein labeled beads and mixtures of the two at different ratios were measured using 
the MATEFFs technique (Figure 4.7).  There is a clear trend shown between the 
fluorescence emission from the two analytes and the changing ratios of the mixtures.  
Though not quantitated, this illustrates that the MATEFFS technique is amenable to 
measurement of multiple analytes in one sample mixture by employing spectrally distinct 
fluorophores and interchanging emission filters. 
 Conventional heterogeneous immunoassays performed in microtiter wells are 
diffusion limited, as the antigen/antibody must migrate to the surface of the well to 
interact with an immobilized antigen/antibody, resulting in reaction solid surface area to 
solution volume ratios (S/V) on the order of 10 cm-1.  A recent report cleverly 
incorporated polystyrene bead solid supports into a glass microchannel using a capture 
dam and reported a S/V of 480 cm-1.99  This improvement in S/V essentially meant a 
larger reaction field and the reaction rate was made 90 times faster compared to a similar 
conventional microtiter plate immunoassay due to a decrease in diffusional distances 
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Figure 4.7  Multi-analye experimental data.  RPE emission is monitored via a 580 nm 
bandpass filter (red bars) and fluorescein emission is monitored via a 532 nm bandpass 
filter (blue bars).  The inset illustrates emission for each fluorophore collected by their 





even further by using an orthogonal magnetic field to hold stationary a plug of magnetic 
beads in a microchannel.  This flow based microimmunoassay resulted in a S/V of 1.3 x 
104 cm-1 within the detection volume, defined by the specific area quantitated within a 
fluorescence micrograph.94  Within the current detection volume for MATEFFs, the 
evanescent wave volume, the S/V is 4.0 x 104 cm-1.  However, MATEFFs is not a 
classical heterogeneous immunoassay.  A unique advantage of the MATEFFs technique 
is that µsphere labeling occurs in free solution without any type of µsphere sequestration 
(weirs, membranes, applied magnetic fields, etc) followed by delivery of the labeled 
µspheres from within the bulk solution to a localized evanescent sensing surface for 
detection.  MATEFFs are not volume limited because the µspheres are able to fully 
interact with the analyte-containing sample before delivery to the detection zone for EW 
probing.  Since it is only necessary to deliver a monolayer of µspheres to the evanescent 
sensing surface, the concentration of magnetic µspheres employed is adjusted 
accordingly and the entire µsphere constituent is interrogated via the EW. By 
concentrating the µsphere volume at the sensing surface, much free solution (or matrix) 
volume is displaced.  This fact, combined with the localized EW, serves to reduce 
background interference from the bulk medium.  It is, therefore, important to illuminate 
the largest possible µsphere surface area, in order to boost analyte density in the EW, 
while limiting the free solution volume within the EW interrogated region.  It is clear 
from calculation (Table 4.2) that, for a given area of EW illumination, matching EW 
penetration depth to the diameter of the µsphere creates an ideal situation whereby 
µsphere surface area interrogated by the EW is maximized and free solution volume is 
minimized.  For ease of comparison, the calculations from Table 4.2 were based on the  
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Table 4.2  Calculations for Optimized Analyte Density.  Optimization of analyte density 
within EW assuming a traditional monolayer µsphere surface coverage within a 10 μm X 
10 μm  square illuminated by the given evanescent wave depth.  In order to perform the 
calculations for this data, equations for the surface area and volume of a spherical cap 
were used to approximate bead surface area and volume.  Additionally, the EW volume 
was calculated assuming a square with dimensions stated above.
Evanescent Wave Depth (d)   
100 nm 200 nm 








100 314 48 314 74 
500 63 73 127 54 











assumption of traditional close packed monolayer coverage for each bead size on the 
prism surface.  It should be noted that as the bead density increases the interfacial optical 
properties of the system may also change. The high specific interface of the MATEFFs 
technique directly relates to the minimization of interference from complicated, non-
optically homogeneous matrices.  The amount of matrix present in the detection volume, 
free solution volume, decreases as the specific interface is increased.  By optimizing 
conditions, as shown in Table 4.2, the specific interface could be increased to 4.0 x 105 
cm-1 while lowering detection limits and minimizing reagent consumption. 
 The following chapter will discuss ongoing MATEFFs studies taking advantage of a 
microfluidic device for multiplexing and passive sample delivery to a localized 
evanescent sensing surface.  Planar waveguide technology is explored for efficient 
surface-confined excitation of magnetically delivered analyte within the evanescent field 
created by waveguide light propagation.   
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CHAPTER 5.                                                                             
MULTIPLEXED, WAVEGUIDE APPROACH TO MAGNETICALLY 
ASSISTED TRANSPORT EVANESCENT FIELD FLUORO-ASSAYS 
Introduction 
 
 Bioaffinity systems, encompassing such techniques as immunoassay and 
oligonucleotide hybridization, are routinely used in clinical, environmental and 
genetic analyses.60, 87, 100, 101  It is important, when dealing with these systems, that 
sample and time are conserved while preserving sensitivity and specificity.  
Moreover, simultaneous parallel analysis of several analytes or samples is desirable.  
Addressing these needs, microfluidic separation and fluid handling systems have 
garnered much attention in the past decade as a portable, small footprint means of 
carrying out chemical and biological processes on a manageable, solvent- and sample-
conserving platform.89  The current work integrates microfluidic and planar 
waveguide technology for simultaneous investigation of multiple bioaffinity systems 
using judicious sequestration of target analyte on magnetically controlled beads, 
thereby facilitating delivery of the target from within a bulk mixture to a localized 
evanescent field sensing surface inside a microfluidic platform.  To our knowledge, 
this represents the seminal report of selective magnetic transport of analyte to a 
localized evanescent field present on the surface of a simple and versatile integrated 
microfluidic/waveguide device. 
 Magnetic microspheres (µspheres) have found utility as solid phases for 
biomolecule immobilization.  In general, µspheres possess a large specific surface for 
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binding, mobility of the solid phase, and an attendant enhancement in interaction of 
the phase surface with passing fluids.  Furthermore, magnetic µspheres permit 
manipulation independent of fluidic flow, making possible the delivery of 
immobilized analytes, be they proteins or small molecules, to a specific zone.    
Magnetic µspheres are amenable to miniaturization and multiplexing using different 
capture probes.  This work expands upon the recently developed magnetically-
assisted transport evanescent field fluoro-assay (MATEFFs), a novel technique 
combining the advantages of both the homogenous and heterogeneous assay while 
eliminating some of the drawbacks, as discussed in the previous chapter.102   
MATEFFs sought to reconcile the advantages of solid support sample concentration 
with the need to eliminate complicated separation steps by, for the first time, 
combining selective magnetic transport of analyte to a highly localized evanescent 
electromagnetic field.  In this work, the electromagnetic field is created using a planar 
waveguide to direct excitation light. 
 Planar waveguide technology makes use of the process of total internal reflectance 
at an optical interface.  The concept of TIR, having previously been discussed, 
basically entails the total reflection of light at an interface under ideal conditons 
except for an exponentially decaying, localized evanescent field.  The evanescent 
field, in the present work, is created at the surface of a standard microscope slide 
used as a type of bulk, planar waveguide with propagation of incident light by way of 
multiple internal reflections.  The implementation of a microscope slide is attractive 
due to the low cost and ease of waveguide development, as compared to other planar 
waveguide systems.80 The process of waveguide excitation was achieved using a 
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cylindrical lens to focus collimated laser light on the edge of the waveguide, 
providing a uniform evanescent sensing surface after a couple of non-collimated 
reflections, as previously described.82  The cylindrical lens results in divergence only 
in the direction of beam propagation, enhancing uniformity while maintaining good 
photon density. 
 The two dimensional microscope slide structure allows for construction of 
multichannel microfluidic architecture on the waveguide surface.  A PDMS 
microfluidic device, conformally sealed to the slide surface, makes possible 
simultaneous interrogation of six analyte samples in separate channels.  Labeled 
magnetic beads are passively pumped, using a previously published method,  through 
microfluidic channels and sequestered within the evanescent wave at the microscope 
slide surface using an external magnet.103  The passive pumping method utilizes the 
surface energy of a droplet placed in the microchannel reservoir to pump liquid 
through the channel.  The only equipment required for this pumping method is a 
pipette, making it simple, effectual and semi-autonomous. A controlled quantity of 
magnetic beads can be efficiently pumped through each microchannel and delivered 
to the waveguide surface using an appropriately placed external magnet.  Thanks to 
the diminutive evanescent field depth, the magnetically delivered analytes can be 
detected with fewer complications arising from nonoptically homogeneous biological 
matrices.  Facile regeneration of the evanescent sensing surface is possible, as a result 
of the ease with which paramagnetic beads are dispersed and recovered in a solution, 
by simply removing the external magnet.  The current technique was optimized using 
a sandwich immunoassay for IgG to determine appropriate experimental conditions.  
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Analytical figures of merit are reported for this technique using IgG and IL-4 
sandwich immunoassays.  Additionally, the potential applicability of this technique to 




 Sodium dihydrogen phosphate, disodium hydrogen phosphate, Tris-HCl, EDTA, 
ethidium bromide, Tween 20, bovine serum albumin (BSA), fluorescein, biotinylated 
anti-rabbit IgG capture antibody, rabbit IgG, and anti-rabbit IgG-R-phycoerythrin 
(RPE) were purchased from Sigma-Aldrich (St. Louis, MO) and used as obtained.  
Biotin anti-human interleukin-4 (IL-4), recombinant human IL-4, and phycoerythrin 
(PE) anti-human IL-4 were purchased from Ebiosciences (San Diego, CA) and used 
as received.  All custom DNA primers (including a biotinylated 100mer strand, the 
100mer complement, and a 100mer non-complement)  were purchased in lyophilized 
form from Invitrogen Corporation (Carlsbad, CA) and reconstituted according to 
Invitrogen recommendations. Sodium chloride (NaCl) was obtained from 
Mallinckrodt, Inc. (Phillipsburg, NJ) and used as received.  Dynabeads® MyOne™ 
Streptavidin C1 superparamagnetic µspheres (1 µm diameter) were purchased from 
Dynal Biotech (Brown Deer, WI) and diluted using phosphate buffered saline (PBS) 
prepared according to Dynal Biotech recommendations.  All buffers and solutions 
were prepared in deionized, distilled water from a Barnstead 1800 purification system 




 A schematic of the instrumental setup is depicted in Figure 5.1.  For immunoassay 
work, the 488-nm beam from an argon-ion laser (Uniphase Model 2201, San Jose, 
CA) was directed through a laser line filter (Edmund Optics, Barrington, NJ) and 
pinhole using first surface mirrors (Edmund Optics, Barrington, NJ).  The beam was 
then sent to a beam steering mirror directly mounted on a rotary stage for controlling 
the incident angle of the laser beam on the microscope slide (waveguide).  To ensure 
the same spot on the waveguide was illuminated with changing angles, the vertical 
position of the rotary stage was controlled via a single axis translational stage.  The 
incident beam was passed through a cylindrical lens (Edmund Optics, Barrington, NJ) 
before reaching the waveguide edge.  The waveguide was positioned using a delrin 
holder fabricated in-house.  The holder contained a sliding block, which housed a 
pressure-formed neodymium bar magnet rated at 10.7 lb lift (McMaster-Carr, Atlanta, 
GA).  The block was used to slide the magnet beneath the waveguide and remove it 
when necessary.  Additionally, the holder included a side mounted, motorized 
translational stage with an attached cage system housing all collection optics.  
Fluorescence was collected through a biconvex F1 lens, passed through a razor edge 
514 nm Raman filter (Semrock, Rochester, NY), and focused onto a Hamamatsu 
HC120 photomultiplier tube (PMT) (Hamamatsu, Bridgewater, NJ) using another 
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Figure 5.1  Schematic of experimental apparatus.  The cage unit is translated via 











using a longpass filter with cut-off position at 610 nm (Edmund Optics, Barrington, 
NJ) for RPE detection and a narrow bandpass interference filter centered at 532 nm 
(Melles Griot, Rochester, NY) for detection of fluorescein.  DNA hybridization 
studies employed virtually the same optical set-up with the exception of the use of a 
portable 50 mW, 532 nm laser for ethidium bromide excitation (OnPoint Lasers, 
Minneapolis, MN).  Output voltage from the PMT was converted at 1 Hz by a PMD-
1208LS data acquisition board with TracerDaq software (Measurement Computing, 
Middleboro, MA).  The entire cage system could be scanned a total of 12 mm at up to 
425 µm/sec across the surface of the waveguide and could, thus, interrogate six 
microfluidic channels. 
 The six channel microfluidic platform was fabricated from PDMS (Sylgard 184, 
Dow-Corning, Midland, MI) using a previously published procedure with the 
exception of the use of a transparency in place of an aluminum photomask.104   The 
six channels were approximately 450 μm wide, 200 μm deep, and 4.5 cm long.  A 
passive solution pumping method was employed for filling that simply involved 
adjusting the fluid levels at the channel terminating reservoirs.103   The magnet was 
positioned at the approximate channel midpoint.
Labeling of µspheres   .
 IgG.  In order to perform the optimization tests, Dynal Biotech Dynabeads MyOne 
Streptavidin C1 µspheres were fully functionalized, using a sandwich assay format, with 
biotinylated anti-rabbit IgG as the capture antibody; rabbit-IgG as the antigen; and anti-
rabbit IgG RPE as the reporter antibody.  The µspheres were first washed with PBS and 
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diluted to 1 mg/mL.  A 400 μL aliquot of µspheres was then removed, separated using an 
external magnet, resuspended in 400 μL of biotinylated anti-rabbit IgG (0.05 mg/mL) and 
allowed to incubate for one hour with gentle rotation.  These µspheres were considered 
fully biotinylated.  The µspheres were then separated, washed two times with PBS, one 
time with 0.01% Tween 20 in PBS, resuspended in 400 μL of rabbit-IgG (0.5 mg/mL) 
and again allowed to incubate for one hour with gentle rotation.  These fully antigen 
labeled µspheres were again separated, washed as described previously and resuspended 
in 400 μL of anti-rabbit IgG RPE (0.05 mg/mL).  Lastly, the µspheres were separated, 
washed and resuspended in 400 μL of PBS.  This fully labeled µsphere solution was used 
for all optimization experiments.  Labeling steps for generation of a calibration curve 
were basically the same as described above, except for the concentration of rabbit IgG 
antigen.  After dividing into 50 µL aliquots, rabbit IgG standards ranging in concentration 
from 20 to 200,000 ng/mL were used, followed by full labeling with the reporter 
antibody. 
 IL-4.  For IL-4 studies, 500 µL of pre-washed Dynal µspheres (1 mg/mL) were 
separated using an external magnet, washed and resuspended for a 30 minute 
incubation with rotation in 500 µL of biotin anti-human interleukin-4 (0.05 mg/mL).  
These beads were then washed as previously described and resuspended in the same 
volume.  Aliquots were removed (50 µL) and diluted to 100 µL for incubation with 
appropriate concentrations of interleukin-4 antigen followed by labeling with 
phycoerythrin anti-human IL-4 (.025 mg/mL).   
 DNA.  Following the protocol from Dynal Biotech for biotinylated oligonucleotide 
labeling, the µspheres were first washed and resuspended in a 2x Binding & Washing 
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(B&W) buffer at a concentration of 1 mg/mL.  To this solution was added an equal 
volume of TE buffer containing 50 pmol of biotinylated DNA.  This mixture was 
incubated with rotation for 15 minutes followed by three wash steps with 1x B&W.  
The µspheres are then resuspended in 100 µL of either complement or non-
complement DNA (50 pmol) and incubated for 15 minutes, followed by wash steps.  
The dsDNA complex was then resuspended in 5 µM ethidium bromide for subsequent 
fluorescence detection. 
Results and Discussion 
 
 In order to fully exploit the advantages of our previously reported MATEFFs 
technique, this work integrates planar waveguide and microfluidic technology.  This 
is, to our knowledge, the first report detailing magnetic transport of a bioaffinity 
system to a localized evanescent field created on a waveguide surface using 
microfluidic sample delivery.  The application of microfluidics to the field of 
heterogeneous immunoassay is attractive due to consequent improvement in assay 
kinetics, reagent and time consumption, waste production and the possibilities for 
automation.105, 106  Evanescent wave detection has long been used in immunoassay 
research.  Some work in the area of bioaffinity reaction monitoring using  both 
microfluidics and evanescent wave detection has been reported, but requires 
immobilization procedures for the capture element on the transducer surface  and 
employs complicated fluidic systems.80, 107  In the present work, experimental 
conditions were first optimized using a model sandwich immunoassay system for IgG. 
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 The occurrence of total internal reflection (TIR), confining excitation light traveling 
through the waveguide, depends upon laser wavelength, incident angle, and refractive 
indices of the waveguide and surrounding medium.  It is important to establish a set 
of conditions that maximizes depth of EW penetration into the sample channels, and 
thus evanescent field strength, when using the EW to probe molecules at the interface.  
In this work, penetration depth is changed by incrementally varying the angle on the 
mirror steering the incident beam.  Evanescent wave formation was initially 
confirmed by magnetically transporting RPE functionalized μspheres to the 
waveguide surface and scanning through incident angles using the beam-steering 
mirror.  Figure 5.2 illustrates the change in fluorescence emission from the 
magnetically delivered RPE labeled beads with change in incident angle (approaching 
the critical angle).  The fluorescence signal increases in all six microfluidic channels 
until an incident angle of ~71º is reached.  The signal then begins to decrease, 
presumably due to inefficient coupling of light into the waveguide once conditions for 
TIR are no longer satisfied.  PDMS (n ≅ 1.47) was the waveguide surrounding 
medium, as the microfluidic platform was constructed from PDMS, and the critical 
angle for PDMS:glass was calculated to be ~75º.  However, the optimal angle needed 
to be determined experimentally as the use of the cylindrical lens causes a distribution 
of angles impinging on the interface.  Additonally, the refractive index for PDMS 
could vary depending on the curing temperature employed during the fabrication 
process.  Additional experiments were performed for optimization of laser power and 
bead plug concentration.  It was determined that the optimal concentration of beads 
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Figure 5.2  Fluorescence emission from RPE labelled magnetic µspheres in each of six 
microfluidic channels with change in incident angle (approaching critical angle).  








laser power linearly increased from 1.5 to 12 mW (data not shown).  Further 
experiments were performed using a 0.5 µg bead plug and ~10mW laser power 
 A benefit of evanescent wave detection is the localization of the electromagnetic 
field to the waveguide surface.  In this case, the analytes are delivered to this surface 
and, even in the presence of background interferents, can be detected without call for  
multiple wash steps.  This fact is evidenced in Figure 5.3, where a 1 µM solution of 
fluorescein was used as model interferent.  Figure 5.3A measures the signal at 532 
nm, which originates primarily from background fluorescein (blue bars).  When 
magnetic beads are added to the fluorescein solution and a field transported plug is 
formed, the fluorescein signal sharply decreases due to the displacement of matrix 
volume in the evanescent field by the µspheres (black bars).  Additionally, Figure 
5.3B depicts the signal measured by the longpass filter with a cut-off position at 610 
nm, which results from bead immobilized RPE (red bars).  This signal in the presence 
of 1 µM fluorescein is only slightly decreased, presumably due to absorbance of some 
evanescent radiation by fluorescein present at the waveguide surface (black bars).  
Therefore, fluorescence measurements for the analyte of interest can be accomplished 
in the presence of background matrix, and bead delivery actually aids in matrix 
displacement from the EW. 
 As laser light travels through the waveguide, it naturally decays as a result of 
waveguide losses, such as absorbance or scattering.  This is evidenced in Figure 5.2 
by the fact that the signal decreases as the EW propagates longitudinally from channel 

































Figure 5.3  Determination of matrix interference effects using RPE labelled magnetic 
beads with 1 µM fluorescein as background matrix.   A)  Fluorescence emission of 
fluorescein measured at 532 nm with (black bars) and without (blue bars) magnetic 
beads.  B)  Fluorescence emission of RPE measured at 580 nm with (black bars) and 
without (red bars) fluorescein.   
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experiment was performed  whereby change in signal from a 1 µM fluorescein 
solution was measured across the six channels and used to normalize data.  The 
normalization plot (Figure 5.4) exhibited a ~6% decrease/channel in signal from 
channel 1 to 6. 
 The linear dynamic range and detection limits of this immunoassay technique were 
evaluated by constructing a calibration curve for detection of rabbit IgG.  Standard 
solutions of rabbit IgG ranging in concentration from 20 to 20,000 ng/mL were tested.   
As shown in Figure 5.5, a quite respectable linear dynamic range (y(V) = 0.0005x 
(mg/mL) + 1.156) of nearly 3 orders of magnitude is established (R2=0.997) with a 
limit of detection of ~120 ng/mL (800 pM).   
 To demonstrate selectivity, a sandwich immunoassay for the detection of 
interleukin-4 (IL-4), a cytokine which promotes proliferation and differentiation of B 
cells, was employed.  IL-4 was detected with an RSD of 5% at four different 
concentrations.  IgG was used as a model cross reactant to test specificity of the IL-4 
sandwich immunoassay.  The fluorescence emission for 700 ng/mL IgG was less than 
2% that of an equivalent concentration of IL-4 (Figure 5.6).  Additionally, using the 
four measured concentrations of IL-4 to generate a best fit line, a detection limit of 10 
ng/mL was established (R2=0.999).   
 In order for miniaturized assay systems to compete with accepted macroscopic 
techniques in terms of sensitivity, the detectable signal must be maximized along with 
minimization of background.   Since, in sandwich immunoassays, only those analyte 
molecules bound to capture antibody will generate a signal upon binding of the 



















Figure 5.4  Normalization plot illustrating decrease in emission from the six channels as 




















































Figure 5.5  Calibration curve using a sandwich immunoassay for detection of IgG.  The 
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Figure 5.6  Calibration data for interleukin-4 .  Four different concentrations of IL-4 were 
measured and are shown.  The inset illustrates the best fit line for these four 
measurements.  Using this data, an RSD of 5% was calculated with a detection limit for 









the affinity binding equilibrium, sandwich immunoassays have been classified as 
either “ambient analyte” or “mass-sensing” assays based upon how analyte 
concentration in solution is changed upon binding to capture antibody.72  For an 
ambient analyte assay, a small amount (e.g., <1.5%) of the total analyte concentration  
is bound to capture antibody, whereas a mass sensing assay could result in near 
complete depletion of antigen from a sample solution (~ 100% bound).  This means 
that for a given concentration of analyte solution, the measured signal from an 
ambient analye assay will not change with changes in assay volume.  Conversely,  a 
mass sensing assay will yield a signal proportional to the actual amount (mass) of 
analyte present in solution.108 
 It follows, then, that analyte harvesting by a mass sensing assay would decrease 
detection limits by permitting detection of practically all analyte molecules present in 
a given sample.  The ability of a given assay to exhibit mass sensing characteristics is 
attributed to a capture antibody concentration greater than 0.01/K (where Ka a is the 
affinity constant) and/or high Ka values.  If higher affinity antibodies are not 
available, then the density of capture antibody in a given area must be increased in 
order to improve sensitivity.  This is a difficult task, since high density arrays 
normally require sophisticated and expensive printing processes.  However, using the 
technique described herein, we illustrate mass sensing behavior that also has the 
inherent advantage of efficient magnetic bead mixing  with the sample.  Furthermore, 
the “concentrated” bound analyte can then be delivered to a localized field for 
detection in a miniaturized volume.  To demonstrate the ability of the technique to 
perform mass sensing, a sample of IL-4 at a concentration of 700 ng/mL was divided 
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into four aliquots, with three of the aliquots diluted to concentrations of 350, 233, and 
140 ng/mL by incrementally increasing the sample volume.  The actual analyte mass 
stayed the same in all samples, although the concentration decreased.  Each analyte 
sample was then used to label the magnetic beads and fluorescence emission was 
measured as previously described.  The fluorescence measurements from each of 
these samples resulted in an RSD of only 12% (data not shown).  This is significant 
because it demonstrates that changes in the effective concentration of the analyte 
solution (up to a 5x dilution) did not result in a proportional decrease in signal.  This 
is because the signal reflected the amount of analyte present, or actual mass of 
analyte.  Based on these results, this method appears to operate as a mass sensing 
assay with actual harvesting of all analyte present in the sample.  The incubation 
times for all samples were the same, although the solution volumes were different.  
The RSD value may have been lowered by increasing incubation time for larger 
volume samples to ensure complete mixing.  Consequently, the actual concentration 
detection limits stated for the IL-4 assay could be made significantly lower by 
increasing sample volume.  It is especially significant that the magnetic beads act as 
analyte harvesters as they are the ultimate means of analyte delivery to the localized 
detection zone and, moreover, decrease background interference due to the matrix 
volume displacement upon magnetic delivery. 
 As a final example of versatility, the technique was applied to detection of DNA 
hybridization via fluorescence emission from ethidium bromide intercalator.  While, 
in genetic studies, it is currently important to apply high density oligonucleotide 
arrays to gene expression monitoring, there is also a need for methods to rapidly 
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analyze samples based on a specific question related to such issues as disease 
diagnosis and susceptibility, or drug discovery.107-109  The work reported herein is a 
preliminary step seeking to demonstrate the potential of this method in such specific 
analysis.  A single stranded DNA 100mer was immobilized on the magnetic bead, 
followed by incubation with either a complementary or non-complementary strand in 
the presence of ethidium bromide (EB).  EB, upon intercalation into the DNA double 
helix, undergoes a fluorescence enhancement.  Therefore, successful DNA 
hybridization should be detectable via measurable increase in EB fluorescence 
emission as compared to EB background from running buffer.110   Figure 5.7 depicts 
the results for the comparison of DNA with complement compared to non-
complement hybridization in the presence of EB running buffer.  The signal from 
complement hybridization was nearly 300% greater than that for non-complement 
after EB background subtraction.    This suggests that the technique could find 
application in genetic analyses.  The system described herein is non-ideal due to 
possible electrostatic interaction of EB with ssDNA and regions of homo-duplex 
formation in the ssDNA 100mer sequences.  Addressing these issues, with the use of 
a better intercalator that is more specific for dsDNA and/or shorter DNA sequences, 
could improve discrimination between complement and non-complement.  
Additionally, conditions such as temperature, salt concentration, and ssDNa binding 
density could be investigated and optimized.  Upon completion of these steps, the 
presence of a specific disease-related sequence upon hybridization to its complement 






ssDNA with  
non-complement 
Ethidium Bromide 



















Figure 5.7  Comparison of fluorescence emission for complement vs. non-complement 







via changes in EB fluorescence using this simple lab-on-a-chip platform without need 
for pre-labeling steps or expensive instrumentation and complicated data analysis 
required for the use of current DNA microarrays.   
Conclusions and Future Work 
 
 This work represents the integration of microfluidic and planar waveguide 
technology for simultaneous investigation of multiple bioaffinity systems.  A simple 
PDMS microfluidic platform is employed for delivery of magnetic bead containing 
solution using a passive pumping technique which circumvents the need for 
sophisticated and expensive external equipment.  Furthermore, the waveguide is a 
basic microscope slide which provides a planar surface for microfluidic attachement  
and efficiently propagates the EW uniformly across six channels.  The use of 
magnetic beads as a mechanism of analyte delivery to the localized evanescent field  
on the waveguide surface eliminates the need for multiple wash steps and 
simultaneously minimizes interference from fluorescing species in the sample matrix 
via displacement of matrix volume.  The ease of magnetic bead dispersement in 
solution upon removal of the external magnet facilitates regeneration of the 
evanescent sensing surface.  In essence, this novel bioassay method has the 
advantages of the homogeneous assay, in that measurements can be made in the 
presence of the sample matrix, and the heterogeneous assay, in that the analyte is 
concentrated on the surface of a solid and mobile substrate.  However, unlike regular 
heterogeneous assays, assay kinetics resemble liquid phase due to the enhancement of 
interaction between magnetic beads and the analyte-containing sample.   
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 Future work could take advantage of the mass sensing characteristics of this system 
to substantially lower detection limits for the bioaffinity systems described herein.  
The use of integrated optical waveguides (IOWs) in the place of the bulk, planar 
waveguide used in the current work, though complicated in terms of fabrication, 
could reduce detection limits up to two orders of magnitude.80  With IOWs, the 
waveguide thickness is comparable to the wavelength of propagating light and it is 
possible to achieve 104 reflections/cm.  However, coupling light into these devices is 
quite difficult, normally requiring prisms or gratings.  Furthermore, using magnetic 
beads that more closely approximate the dimensions of the EW depth could lower 
detection limits by maximizing the probed surface area and minimizing matrix 
volume in the EW.  More sophisticated PDMS architectures could also be utilized for 
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